<html>
<head>
<META HTTP-EQUIV='Content-Type' CONTENT='text/html; charset=big5'>
<?xml version="1.0" encoding="UTF-8"?> 
<html xmlns="http://www.w3.org/1999/xhtml"
xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2017-03-09/ifrs-full"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
xmlns:tifrs-SCF="http://www.xbrl.org/tifrs/scf/2020-06-30"
xmlns:tifrs-ar="http://www.xbrl.org/tifrs/ar/2020-06-30"
xmlns:tifrs-bsci-ci="http://www.xbrl.org/tifrs/bsci/ci/2020-06-30"
xmlns:tifrs-es="http://www.xbrl.org/tifrs/es/2020-06-30"
xmlns:tifrs-notes="http://www.xbrl.org/tifrs/notes/2020-06-30">
<head> 
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 
	<title> 1734 2023Q4 Financial report</title> 
	<script src="https://code.jquery.com/jquery-3.2.1.min.js" type="text/javascript"></script> 
	<script type="text/javascript"> 
		/*<![CDATA[*/ 
		function showChineseReport() { 
			$(".zh").show();
			$(".en").hide();
		}
		function showEnglishReport() {
			$(".en").show();
			$(".zh").hide();
		}
		$(document).ready(function() { 
			if (location.search.indexOf("?") != -1 && 
			location.search.split("?")[1].split("=")[1] == "en") 
				showEnglishReport(); 
			else 
				showChineseReport(); 
		});	
		/*]]>*/ 
	</script> 
	<style type="text/css"> 
		body,html {height: 100%;} 
		body {font-size: 15px;font-family: Arial;color: #000;background: #4E5869;margin: 0;padding: 0;background-color: #FFF;} 
		td,th {border: 1px solid #dddddd;padding: 5px;color: #333;background-color: #FFF;} 
		th#t1 {color: #165c98 !important;} 
		ul,ol,dl {padding: 0;margin: 0;} 
		h3 {color: #165c98;font-size: 18px;} 
		pre {font-size: 15px;font-family: Arial;} 
		.container {width: 100%;background: #FFF;margin: 0 auto;background-color: #999;} 
		.header {text-align: center;background: #165c98;margin-right: auto;color: #fff;} 
		.header > div:first-of-type {position: absolute;right: 15px;top: 15px;} 
		.header > div:nth-of-type(2) {font-size: 25px;text-align: center;line-height: 35px;} 
		.header a {text-decoration: none;margin:0 10px;color: #ffffff;} 
		.nav {float: left;width: 200px;height: calc(100% - 85px);overflow: auto;background: #fff;padding-bottom: 15px;} 
		.nav > div {padding: 10px;color: #165c98;font-size: 20px;font-weight: bold;} 
		.nav > ul {list-style: none;border-top: 1px solid #666;margin-bottom: 15px;} 
		.nav > ul li{border-bottom: 1px solid #666;} 
		.nav > ul a{padding: 5px 2px 5px 10px;display: block;text-decoration: none;background: #fff;color: #333;} 
		.nav > ul a:hover{background: #165c98;color: #fff;} 
		.content {width: calc(100% - 200px);height: calc(100% - 70px); float: left;background: #efefef;overflow: auto;} 
		.content > div[id*="link"] {height: 15px;} 
		.content table {border-collapse: collapse;margin: 0 20px;} 
		.content ul, 
		.content ol {padding: 15px 10px 10px 15px;} 
		.content table tr th {background: #7fcef5;color: #165c98;} 
		.content table tr:first-child th {background: #165c98;color: #fff;font-size: 15px;text-align: left;} 
		.content table tr:nth-of-type(odd) > td {background-color: #d3edfa;} 
		.title {font-size: 18px;font-weight: bold;margin-left: 20px;} 
		.rptidx {color: #000;margin-left: 20px;} 
		.amt {text-align: right} 
		.note {font-family: 細明體} 
		@media print{ 
			.header a{display: none;} 
			.nav{display: none;} 
			.content{width: 100%;height:auto;float: inherit;overflow: inherit;background: #fff!important;} 
			.content table{width: 100%!important;margin: 0;} 
			body{color: #000;} 
			td,th{color: #000;border: 1px solid #000;} 
		} 
	</style> 
</head> 
<body> 
	<div style="display:none"> 
		<ix:header> 
			<ix:hidden> 
				<ix:nonNumeric name="tifrs-notes:CompanyID" contextRef="From20230101To20231231">1734</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyChineseName" contextRef="From20230101To20231231">杏輝藥品工業股份有限公司</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyEnglishName" contextRef="From20230101To20231231">SINPHAR PHARMACEUTICAL CO.,LTD.</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Year" contextRef="From20230101To20231231">2023</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Quarter" contextRef="From20230101To20231231">4</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportType" contextRef="From20230101To20231231">Financial report (general)</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportCategory" contextRef="From20230101To20231231">Consolidated report</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Market" contextRef="From20230101To20231231">Listed company</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:IndustrySector" contextRef="From20230101To20231231">Commercial and industrial</ix:nonNumeric> 
			</ix:hidden> 
			<ix:references>
				<link:schemaRef xlink:href="tifrs-ci-cr-2020-06-30.xsd" xlink:type="simple"/>
			</ix:references>
			<ix:resources> 
				<xbrli:context id="AsOf20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20240306"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2024-03-06</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">1734</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:unit id="TWD"> 
					<xbrli:measure>iso4217:TWD</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="Shares"> 
					<xbrli:measure>xbrli:shares</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="EarningsPerShare"> 
					<xbrli:divide> 
						<xbrli:unitNumerator> 
							<xbrli:measure>iso4217:TWD</xbrli:measure> 
						</xbrli:unitNumerator> 
						<xbrli:unitDenominator> 
							<xbrli:measure>xbrli:shares</xbrli:measure> 
						</xbrli:unitDenominator> 
					</xbrli:divide> 
				</xbrli:unit> 
				<xbrli:unit id="Pure"> 
					<xbrli:measure>xbrli:pure</xbrli:measure> 
				</xbrli:unit> 
			</ix:resources> 
		</ix:header> 
	</div> 
	<div class="container"> 
		<div class="header"> 
			<div> 
				<a href="javascript:showChineseReport();">中文</a>|<a href="javascript:showEnglishReport();">English</a> 
			</div> 
			<div> 
				<span class="zh">1734 杏輝藥品工業股份有限公司<br />2023年第4季合併財務報告</span> 
				<span class="en">1734 SINPHAR PHARMACEUTICAL CO.,LTD.<br />2023Q4 Consolidated Financial Report</span> 
			</div> 
		</div> 
		<div class="nav"> 
			<div>
				<span class="zh">財務報表索引</span>
				<span class="en">Report Index</span>
			</div> 
			<ul> 
				<li>
					<a href="#BalanceSheet">
						<span class="zh">資產負債表</span>
						<span class="en">Balance Sheet</span>
					</a>
				</li>
				<li>
					<a href="#StatementOfComprehensiveIncome">
						<span class="zh">綜合損益表</span>
						<span class="en">Statement of Comprehensive Income</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfCashFlows">
						<span class="zh">現金流量表</span>
						<span class="en">Statements of Cash Flows</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfChangeInEquity">
						<span class="zh">權益變動表</span> 
						<span class="en">Statements of Change in Equity</span>
					</a>
				</li>
				<span class="zh">
	    			<li><a href="#ReportOfIndependentAuditors">會計師查核（核閱）報告</a></li>
	    		</span>
	    		<span class="en">
	    			<li><a href="#ReportOfIndependentAuditorsEN">Independent Auditors' (Review) Report</a></li>
	    		</span>
				<span class="zh">
	    			<li><a style="background-color:#ceceef;">財務報表附註</a></li>
	    			<li><a href="#HistoryAndOrganization">公司沿革及業務範圍</a></li>
	    			<li><a href="#DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">通過財報之日期及程序</a></li>
	    			<li><a href="#ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">新發布及修訂準則及解釋之適用</a></li>
	    			<li><a href="#SummaryOfSignificantAccountingPolicies">重大會計政策之彙總說明</a></li>
	    			<li><a href="#SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">會計重大判斷、假設及估計不確性之主要來源</a></li>
	    			<li><a style="background-color:#ceceef;">其它財報附註</a></li>
	    			<li><a href="#TradeAndOtherReceivables">應收款項</a></li>
	    			<li><a href="#TransactionsBetweenRelatedParties">關係人交易</a></li>
	    			<li><a href="#LoansToOthers">資金貸與他人</a></li>
	    			<li><a href="#EndorsementGuaranteeProvidedToOthers">為他人背書保證</a></li>
	    			<li><a href="#SignificantIntercompanyTransactionsBetweenConsolidatedEntities">母子公司間業務關係及重要交易往來情形</a></li>
	    			<li><a href="#NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">被投資公司名稱、所在地區…等相關資訊</a></li>
	    			<li><a href="#InvestmentInMainlandChina">大陸地區投資</a></li>
	    			<li><a href="#NonoperatingIncomeAndExpenses">營業外收入及支出</a></li>
				</span>
			</ul> 
		</div> 
		<div class="content"> 
			<!-- 資產負債表 -->
			<div id="BalanceSheet"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">資產負債表</span><span class="en">Balance Sheet</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年12月31日</span><span class="en">2023/12/31</span></th> 
						<th><span class="zh">2022年12月31日</span><span class="en">2022/12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">資產</span><span class="en">Assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　流動資產</span><span class="en">　Current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1100</td> 
						<td><span class="zh">　　現金及約當現金</span><span class="en">　　Cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,074,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,237,556</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1110</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－流動</span><span class="en">　　Current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,660</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,660</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1150</td> 
						<td><span class="zh">　　應收票據淨額</span><span class="en">　　Notes receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">166,213</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">179,136</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1170</td> 
						<td><span class="zh">　　應收帳款淨額</span><span class="en">　　Accounts receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">477,252</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">506,053</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">130X</td> 
						<td><span class="zh">　　存貨</span><span class="en">　　Current inventories</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">839,194</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">737,013</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1410</td> 
						<td><span class="zh">　　預付款項</span><span class="en">　　Prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">79,050</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">107,172</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1470</td> 
						<td><span class="zh">　　其他流動資產</span><span class="en">　　Other current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,747</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,861</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">11XX</td> 
						<td><span class="zh">　　流動資產合計</span><span class="en">　　Total current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,648,605</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,778,451</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　非流動資產</span><span class="en">　Non-current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1510</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1517</td> 
						<td><span class="zh">　　透過其他綜合損益按公允價值衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at fair value through other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">22,212</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,695</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1600</td> 
						<td><span class="zh">　　不動產、廠房及設備</span><span class="en">　　Property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,228,305</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,119,747</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1755</td> 
						<td><span class="zh">　　使用權資產</span><span class="en">　　Right-of-use assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,574</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,562</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1780</td> 
						<td><span class="zh">　　無形資產</span><span class="en">　　Intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,823</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">86,983</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1840</td> 
						<td><span class="zh">　　遞延所得稅資產</span><span class="en">　　Deferred tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">170,856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">52,108</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1900</td> 
						<td><span class="zh">　　其他非流動資產</span><span class="en">　　Other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">90,706</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">103,645</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1915</td> 
						<td><span class="zh">　　　預付設備款</span><span class="en">　　　Prepayments for business facilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:PrepaymentsForBusinessFacilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,855</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:PrepaymentsForBusinessFacilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">65,075</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1920</td> 
						<td><span class="zh">　　　存出保證金</span><span class="en">　　　Guarantee deposits paid</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,324</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,400</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1990</td> 
						<td><span class="zh">　　　其他非流動資產－其他</span><span class="en">　　　Other non-current assets, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentAssetsOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,527</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentAssetsOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,170</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">15XX</td> 
						<td><span class="zh">　　非流動資產合計</span><span class="en">　　Total non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,602,476</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,406,740</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1XXX</td> 
						<td><span class="zh">　資產總計</span><span class="en">　Total assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,251,081</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,185,191</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">負債及權益</span><span class="en">Liabilities and equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　負債</span><span class="en">　Liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　流動負債</span><span class="en">　　Current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2100</td> 
						<td><span class="zh">　　　短期借款</span><span class="en">　　　Current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">400,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">447,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2130</td> 
						<td><span class="zh">　　　合約負債－流動</span><span class="en">　　　Current contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,654</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">96,559</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2150</td> 
						<td><span class="zh">　　　應付票據</span><span class="en">　　　Notes payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">162</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">558</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2170</td> 
						<td><span class="zh">　　　應付帳款</span><span class="en">　　　Accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">291,208</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">323,182</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2200</td> 
						<td><span class="zh">　　　其他應付款</span><span class="en">　　　Other payables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,506</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">426,424</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2219</td> 
						<td><span class="zh">　　　　其他應付款－其他</span><span class="en">　　　　Other payables, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherPayablesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,506</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherPayablesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">426,424</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2230</td> 
						<td><span class="zh">　　　本期所得稅負債</span><span class="en">　　　Current tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,087</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,407</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2300</td> 
						<td><span class="zh">　　　其他流動負債</span><span class="en">　　　Other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">88,077</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">106,781</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2320</td> 
						<td><span class="zh">　　　　一年或一營業週期內到期長期負債</span><span class="en">　　　　Long-term liabilities, current portion</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,716</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,341</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2399</td> 
						<td><span class="zh">　　　　其他流動負債－其他</span><span class="en">　　　　Other current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,361</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,440</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">21XX</td> 
						<td><span class="zh">　　　流動負債合計</span><span class="en">　　　Total current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,204,694</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,445,911</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　非流動負債</span><span class="en">　　Non-current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2540</td> 
						<td><span class="zh">　　　長期借款</span><span class="en">　　　Non-current portion of non-current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,494,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,415,618</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2600</td> 
						<td><span class="zh">　　　其他非流動負債</span><span class="en">　　　Other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">154,371</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">106,814</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2640</td> 
						<td><span class="zh">　　　　淨確定福利負債-非流動</span><span class="en">　　　　Net defined benefit liability, non-current</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,552</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,978</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2670</td> 
						<td><span class="zh">　　　　其他非流動負債－其他</span><span class="en">　　　　Other non-current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">118,819</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">70,836</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">25XX</td> 
						<td><span class="zh">　　　非流動負債合計</span><span class="en">　　　Total non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,648,513</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,522,432</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2XXX</td> 
						<td><span class="zh">　　負債總計</span><span class="en">　　Total liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,853,207</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,968,343</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　權益</span><span class="en">　Equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　歸屬於母公司業主之權益</span><span class="en">　　Equity attributable to owners of parent</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　股本</span><span class="en">　　　Share capital</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3110</td> 
						<td><span class="zh">　　　　普通股股本</span><span class="en">　　　　Ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3100</td> 
						<td><span class="zh">　　　　股本合計</span><span class="en">　　　　Total Share Capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　資本公積</span><span class="en">　　　Capital surplus</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3200</td> 
						<td><span class="zh">　　　　資本公積合計</span><span class="en">　　　　Total capital surplus</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">924,140</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">929,972</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　保留盈餘</span><span class="en">　　　Retained earnings</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3310</td> 
						<td><span class="zh">　　　　法定盈餘公積</span><span class="en">　　　　Legal reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">142,979</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">119,606</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3320</td> 
						<td><span class="zh">　　　　特別盈餘公積</span><span class="en">　　　　Special reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,367</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,075</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3350</td> 
						<td><span class="zh">　　　　未分配盈餘（或待彌補虧損）</span><span class="en">　　　　Unappropriated retained earnings (accumulated deficit)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">369,802</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3300</td> 
						<td><span class="zh">　　　　保留盈餘合計</span><span class="en">　　　　Total retained earnings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">634,148</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">444,405</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　其他權益</span><span class="en">　　　Other equity interest</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3400</td> 
						<td><span class="zh">　　　　其他權益合計</span><span class="en">　　　　Total other equity interest</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">137,171</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">121,368</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">31XX</td> 
						<td><span class="zh">　　　歸屬於母公司業主之權益合計</span><span class="en">　　　Total equity attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,098,338</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,930,230</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">36XX</td> 
						<td><span class="zh">　　非控制權益</span><span class="en">　　Non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">299,536</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,618</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3XXX</td> 
						<td><span class="zh">　　權益總額</span><span class="en">　　Total equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,397,874</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,216,848</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3X2X</td> 
						<td><span class="zh">　負債及權益總計</span><span class="en">　Total liabilities and equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,251,081</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,185,191</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3997</td> 
						<td><span class="zh">　待註銷股本股數</span><span class="en">　Number of share capital awaiting retirement</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfShareCapitalAwaitingRetirement" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfShareCapitalAwaitingRetirement" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3998</td> 
						<td><span class="zh">　預收股款（權益項下）之約當發行股數</span><span class="en">　Equivalent issue shares of advance receipts for ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3999</td> 
						<td><span class="zh">　母公司暨子公司所持有之母公司庫藏股股數（單位：股）</span><span class="en">　Number of shares in entity held by entity and by its subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 綜合損益表 -->
			<div id="StatementOfComprehensiveIncome"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元　每股盈餘單位：新台幣元</span><span class="en">Unit: NT$ thousands　EPS Unit: NT$</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">綜合損益表</span><span class="en">Statement of Comprehensive Income</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業收入</span><span class="en">Operating revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4000</td> 
						<td><span class="zh">　營業收入合計</span><span class="en">　Total operating revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,962,934</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,856,651</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業成本</span><span class="en">Operating costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5000</td> 
						<td><span class="zh">　營業成本合計</span><span class="en">　Total operating costs</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,871,691</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,765,351</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5900</td> 
						<td><span class="zh">營業毛利（毛損）</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,091,243</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,091,300</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5950</td> 
						<td><span class="zh">營業毛利（毛損）淨額</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,091,243</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,091,300</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業費用</span><span class="en">Operating expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6100</td> 
						<td><span class="zh">　推銷費用</span><span class="en">　Selling expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">446,775</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">408,272</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6200</td> 
						<td><span class="zh">　管理費用</span><span class="en">　Administrative expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,151</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">213,063</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6300</td> 
						<td><span class="zh">　研究發展費用</span><span class="en">　Research and development expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">132,580</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">272,163</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6450</td> 
						<td><span class="zh">　預期信用減損損失(利益)</span><span class="en">　Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,681</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">467</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6000</td> 
						<td><span class="zh">　營業費用合計</span><span class="en">　Total operating expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">805,187</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">893,965</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6900</td> 
						<td><span class="zh">營業利益（損失）</span><span class="en">Net operating income (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,056</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">197,335</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業外收入及支出</span><span class="en">Non-operating income and expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　利息收入</span><span class="en">　Interest income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7101</td> 
						<td><span class="zh">　　銀行存款利息</span><span class="en">　　Interest income from bank deposits</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestIncomeOnDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,307</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestIncomeOnDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,776</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7100</td> 
						<td><span class="zh">　　利息收入合計</span><span class="en">　　Total interest income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,307</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,776</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他收入</span><span class="en">　Other income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7190</td> 
						<td><span class="zh">　　其他收入－其他</span><span class="en">　　Other income, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherIncomeOthers" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherIncomeOthers" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,707</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7010</td> 
						<td><span class="zh">　　其他收入合計</span><span class="en">　　Total other income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,707</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他利益及損失</span><span class="en">　Other gains and losses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7020</td> 
						<td><span class="zh">　　其他利益及損失淨額</span><span class="en">　　Other gains and losses, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,041</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　財務成本</span><span class="en">　Finance costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7050</td> 
						<td><span class="zh">　　財務成本淨額</span><span class="en">　　Finance costs, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,711</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,813</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7000</td> 
						<td><span class="zh">　營業外收入及支出合計</span><span class="en">　Total non-operating income and expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,652</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,711</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7900</td> 
						<td><span class="zh">繼續營業單位稅前淨利（淨損）</span><span class="en">Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">305,708</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">245,046</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">所得稅費用（利益）</span><span class="en">Tax expense (income)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7950</td> 
						<td><span class="zh">　所得稅費用（利益）合計</span><span class="en">　Total tax expense (income)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">51,068</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,872</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8000</td> 
						<td><span class="zh">繼續營業單位本期淨利（淨損）</span><span class="en">Profit (loss) from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">356,776</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">164,174</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8200</td> 
						<td><span class="zh">本期淨利（淨損）</span><span class="en">Profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">356,776</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">164,174</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">其他綜合損益(淨額)</span><span class="en">Other comprehensive income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　不重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8311</td> 
						<td><span class="zh">　　確定福利計畫之再衡量數</span><span class="en">　　Gains (losses) on remeasurements of defined benefit plans</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,736</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,080</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8316</td> 
						<td><span class="zh">　　透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益</span><span class="en">　　Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,933</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesFromInvestmentsInEquityInstruments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,340</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8310</td> 
						<td><span class="zh">　　不重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,669</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,740</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　後續可能重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8361</td> 
						<td><span class="zh">　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　Exchange differences on translation</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,186</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,874</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8399</td> 
						<td><span class="zh">　　與可能重分類之項目相關之所得稅</span><span class="en">　　Income tax related to components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,009</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,784</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8360</td> 
						<td><span class="zh">　　後續可能重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,177</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,090</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8300</td> 
						<td><span class="zh">　其他綜合損益（淨額）</span><span class="en">　Total other comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,846</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,830</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8500</td> 
						<td><span class="zh">本期綜合損益總額</span><span class="en">Total comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">332,930</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">182,004</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">淨利（損）歸屬於：</span><span class="en">Profit (loss), attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8610</td> 
						<td><span class="zh">　母公司業主（淨利／損）</span><span class="en">　Profit (loss), attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,170</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,644</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8620</td> 
						<td><span class="zh">　非控制權益（淨利／損）</span><span class="en">　Profit (loss), attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">60,470</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">綜合損益總額歸屬於：</span><span class="en">Comprehensive income attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8710</td> 
						<td><span class="zh">　母公司業主（綜合損益）</span><span class="en">　Comprehensive income, attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">355,631</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">241,535</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8720</td> 
						<td><span class="zh">　非控制權益（綜合損益）</span><span class="en">　Comprehensive income, attributable to non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,701</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">59,531</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">基本每股盈餘</span><span class="en">Basic earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9750</td> 
						<td><span class="zh">　基本每股盈餘合計</span><span class="en">　Total basic earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">2.24</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">1.34</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">稀釋每股盈餘</span><span class="en">Diluted earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9850</td> 
						<td><span class="zh">　稀釋每股盈餘合計</span><span class="en">　Total diluted earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">2.23</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">1.34</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 現金流量表 -->
			<div id="StatementsOfCashFlows"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">現金流量表</span><span class="en">Statements of Cash Flows</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業活動之現金流量－間接法</span><span class="en">Cash flows from (used in) operating activities, indirect method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00010</td> 
						<td><span class="zh">　繼續營業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">305,708</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">245,046</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A10000</td> 
						<td><span class="zh">　本期稅前淨利（淨損）</span><span class="en">　Profit (loss) before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">305,708</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">245,046</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　調整項目</span><span class="en">　Adjustments</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　收益費損項目</span><span class="en">　　Adjustments to reconcile profit (loss)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20100</td> 
						<td><span class="zh">　　　折舊費用</span><span class="en">　　　Depreciation expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">206,727</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,849</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20200</td> 
						<td><span class="zh">　　　攤銷費用</span><span class="en">　　　Amortization expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,797</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">65,865</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20300</td> 
						<td><span class="zh">　　　預期信用減損損失（利益）數／呆帳費用提列（轉列收入）數</span><span class="en">　　　Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,681</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProvisionReversalOfProvisionForBadDebtExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">467</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20900</td> 
						<td><span class="zh">　　　利息費用</span><span class="en">　　　Interest expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,711</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,813</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21200</td> 
						<td><span class="zh">　　　利息收入</span><span class="en">　　　Interest income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,307</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,776</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22500</td> 
						<td><span class="zh">　　　處分及報廢不動產、廠房及設備損失（利益）</span><span class="en">　　　Loss (gain) on disposal of property, plan and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,126</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">811</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A29900</td> 
						<td><span class="zh">　　　其他項目</span><span class="en">　　　Other adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">60,370</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20010</td> 
						<td><span class="zh">　　　收益費損項目合計</span><span class="en">　　　Total adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">201,113</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">290,029</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　與營業活動相關之資產／負債變動數</span><span class="en">　　Changes in operating assets and liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之資產之淨變動</span><span class="en">　　　Changes in operating assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31130</td> 
						<td><span class="zh">　　　　應收票據（增加）減少</span><span class="en">　　　　Decrease (increase) in notes receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,769</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,138</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31150</td> 
						<td><span class="zh">　　　　應收帳款（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,285</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">73,590</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31200</td> 
						<td><span class="zh">　　　　存貨（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in inventories</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">102,181</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,620</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31230</td> 
						<td><span class="zh">　　　　預付款項（增加）減少</span><span class="en">　　　　Decrease (increase) in prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,232</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,897</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31240</td> 
						<td><span class="zh">　　　　其他流動資產（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in other current assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">148</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,320</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31000</td> 
						<td><span class="zh">　　　　與營業活動相關之資產之淨變動合計</span><span class="en">　　　　Total changes in operating assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">37,043</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">80,131</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之負債之淨變動</span><span class="en">　　　Changes in operating liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32125</td> 
						<td><span class="zh">　　　　合約負債增加（減少）</span><span class="en">　　　　Increase (decrease) in contract liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,905</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,922</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32130</td> 
						<td><span class="zh">　　　　應付票據增加（減少）</span><span class="en">　　　　Increase (decrease) in notes payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">396</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">395</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32150</td> 
						<td><span class="zh">　　　　應付帳款增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">31,974</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,921</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32180</td> 
						<td><span class="zh">　　　　其他應付款增加（減少）</span><span class="en">　　　　Increase (decrease) in other payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">26,522</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">99,220</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32230</td> 
						<td><span class="zh">　　　　其他流動負債增加（減少）</span><span class="en">　　　　Adjustments for increase (decrease) in other current liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,079</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,571</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32240</td> 
						<td><span class="zh">　　　　淨確定福利負債增加(減少)</span><span class="en">　　　　Increase (decrease) in net defined benefit liability</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccruedPensionLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,162</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccruedPensionLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,831</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32990</td> 
						<td><span class="zh">　　　　其他營業負債增加（減少）</span><span class="en">　　　　Increase (decrease) in other operating liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,648</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,413</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32000</td> 
						<td><span class="zh">　　　　與營業活動相關之負債之淨變動合計</span><span class="en">　　　　Total changes in operating liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">94,686</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,345</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A30000</td> 
						<td><span class="zh">　　　與營業活動相關之資產及負債之淨變動合計</span><span class="en">　　　Total changes in operating assets and liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">131,729</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,786</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20000</td> 
						<td><span class="zh">　　調整項目合計</span><span class="en">　　Total adjustments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">69,384</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">249,243</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33000</td> 
						<td><span class="zh">　營運產生之現金流入（流出）</span><span class="en">　Cash inflow (outflow) generated from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,092</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">494,289</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33100</td> 
						<td><span class="zh">　收取之利息</span><span class="en">　Interest received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,301</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,751</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33300</td> 
						<td><span class="zh">　支付之利息</span><span class="en">　Interest paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,651</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">27,644</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33500</td> 
						<td><span class="zh">　退還（支付）之所得稅</span><span class="en">　Income taxes refund (paid)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">57,372</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,098</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">AAAA</td> 
						<td><span class="zh">營業活動之淨現金流入（流出）</span><span class="en">Net cash flows from (used in) operating activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">296,370</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">425,298</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">投資活動之現金流量</span><span class="en">Cash flows from (used in) investing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00010</td> 
						<td><span class="zh">　取得透過其他綜合損益按公允價值衡量之金融資產</span><span class="en">　Acquisition of financial assets at fair value through other comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,450</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">9,676</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00050</td> 
						<td><span class="zh">　處分按攤銷後成本衡量之金融資產</span><span class="en">　Proceeds from disposal of financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,440</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02700</td> 
						<td><span class="zh">　取得不動產、廠房及設備</span><span class="en">　Acquisition of property, plant and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">198,725</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">82,166</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02800</td> 
						<td><span class="zh">　處分不動產、廠房及設備</span><span class="en">　Proceeds from disposal of property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,300</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">243</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03700</td> 
						<td><span class="zh">　存出保證金增加</span><span class="en">　Increase in refundable deposits</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,924</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03800</td> 
						<td><span class="zh">　存出保證金減少</span><span class="en">　Decrease in refundable deposits</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInRefundableDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,418</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04500</td> 
						<td><span class="zh">　取得無形資產</span><span class="en">　Acquisition of intangible assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,426</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,963</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B06700</td> 
						<td><span class="zh">　其他非流動資產增加</span><span class="en">　Increase in other non-current assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInOtherAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">30,553</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInOtherAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,218</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B07100</td> 
						<td><span class="zh">　預付設備款增加</span><span class="en">　Increase in prepayments for business facilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInPrepaymentsForBusinessFacilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">96,785</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInPrepaymentsForBusinessFacilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">59,316</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">BBBB</td> 
						<td><span class="zh">　投資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) investing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">334,563</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">124,238</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">籌資活動之現金流量</span><span class="en">Cash flows from (used in) financing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00200</td> 
						<td><span class="zh">　短期借款減少</span><span class="en">　Decrease in short-term loans</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,000</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">140,000</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01600</td> 
						<td><span class="zh">　舉借長期借款</span><span class="en">　Proceeds from long-term debt</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">160,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">180,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01700</td> 
						<td><span class="zh">　償還長期借款</span><span class="en">　Repayments of long-term debt</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">81,101</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">259,065</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C03100</td> 
						<td><span class="zh">　存入保證金減少</span><span class="en">　Decrease in guarantee deposits received</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInGuaranteeDepositsReceived" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">666</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInGuaranteeDepositsReceived" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04400</td> 
						<td><span class="zh">　其他非流動負債減少</span><span class="en">　Decrease in other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInOtherLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInOtherLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,896</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04500</td> 
						<td><span class="zh">　發放現金股利</span><span class="en">　Cash dividends paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">167,722</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,544</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04600</td> 
						<td><span class="zh">　現金增資</span><span class="en">　Proceeds from issuing shares</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,043</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05800</td> 
						<td><span class="zh">　非控制權益變動</span><span class="en">　Change in non-controlling interests</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,225</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,795</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">CCCC</td> 
						<td><span class="zh">　籌資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) financing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">120,671</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">263,325</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">DDDD</td> 
						<td><span class="zh">匯率變動對現金及約當現金之影響</span><span class="en">Effect of exchange rate changes on cash and cash equivalents</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,203</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,036</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">EEEE</td> 
						<td><span class="zh">本期現金及約當現金增加（減少）數</span><span class="en">Net increase (decrease) in cash and cash equivalents</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">163,067</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">42,771</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00100</td> 
						<td><span class="zh">期初現金及約當現金餘額</span><span class="en">Cash and cash equivalents at beginning of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,237,556</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,194,785</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00200</td> 
						<td><span class="zh">期末現金及約當現金餘額</span><span class="en">Cash and cash equivalents at end of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,074,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,237,556</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00210</td> 
						<td><span class="zh">　資產負債表帳列之現金及約當現金</span><span class="en">　Cash and cash equivalents reported in the statement of financial position</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,074,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,237,556</ix:nonFraction> </pre></td>
					</tr> 

				</table> 
				<br /> 
			<!-- 當期權益變動表 -->
			<div id="StatementsOfChangeInEquity"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">當期權益變動表</span><span class="en">Statements of Change in Equity</span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3400</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">929,972</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">119,606</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,075</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">444,405</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">80,701</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,667</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">121,368</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,930,230</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,618</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,216,848</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,373</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,373</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B3</td> 
						<td> 
							<span class="zh">提列特別盈餘公積</span> 
							<span class="en">　　Special reserve appropriated</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,292</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">30,292</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">167,722</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">167,722</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">167,722</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">167,722</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,170</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,170</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">375,170</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">356,776</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,736</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,736</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,019</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,784</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,803</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,539</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,307</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,846</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371,434</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371,434</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,019</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,784</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,803</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">355,631</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,701</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">332,930</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M7</td> 
						<td> 
							<span class="zh">對子公司所有權權益變動</span> 
							<span class="en">　Changes in ownership interests in subsidiaries</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,832</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">13,969</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">13,969</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,801</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">49,844</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,043</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>O1</td> 
						<td> 
							<span class="zh">非控制權益增減</span> 
							<span class="en">　Changes in non-controlling interests</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,225</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,225</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,832</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,373</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,292</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">136,078</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">189,743</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,019</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,784</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">15,803</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">168,108</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,918</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">181,026</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">924,140</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">142,979</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">121,367</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">369,802</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">634,148</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">92,720</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">44,451</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">137,171</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,098,338</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">299,536</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,397,874</ix:nonFraction> </pre></td>
					</tr>
				</table> 
				<br /> 
			<!-- 去年同期權益變動表 -->
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">去年同期權益變動表</span><span class="en"> Last year's Statements of Change in Equity </span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3400</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">963,516</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,734</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,075</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">34,128</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">210,681</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">91,854</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">37,325</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">129,179</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,722,239</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">354,944</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,077,183</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B13</td> 
						<td> 
							<span class="zh">法定盈餘公積彌補虧損</span> 
							<span class="en">　　Legal reserve used to offset accumulated deficits</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveUsedToOffsetAccumulatedDeficits" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">34,128</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveUsedToOffsetAccumulatedDeficits" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,128</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveUsedToOffsetAccumulatedDeficits" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveUsedToOffsetAccumulatedDeficits" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveUsedToOffsetAccumulatedDeficits" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C15</td> 
						<td> 
							<span class="zh">資本公積配發現金股利</span> 
							<span class="en">　　Cash dividends from capital surplus</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsFromCapitalSurplus" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,544</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsFromCapitalSurplus" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,544</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsFromCapitalSurplus" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,544</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,644</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,644</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,644</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">60,470</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">164,174</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,080</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,080</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,153</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,342</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,811</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,891</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">939</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,830</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,153</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,342</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,811</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">241,535</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">59,531</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">182,004</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>O1</td> 
						<td> 
							<span class="zh">非控制權益增減</span> 
							<span class="en">　Changes in non-controlling interests</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,795</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,795</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">33,544</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">34,128</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">267,852</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,153</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,342</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,811</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">207,991</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">68,326</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">139,665</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,677,221</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">929,972</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">119,606</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,075</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">233,724</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">444,405</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">80,701</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,667</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">121,368</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,930,230</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,618</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,216,848</ix:nonFraction> </pre></td>
					</tr>

				</table> 
				<br /> 
			<!-- 會計師查核報告 -->	
			<div id="ReportOfIndependentAuditors"></div> 
			<span class="zh">
			<div class="rptidx">單位：新臺幣仟元</div> 
				<table> 
					<tr>
						<th colspan="3">會計師查核（核閱）報告</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師事務所名稱</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20240306" xml:lang="zh" escape="true">國富浩華聯合會計師事務所</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20240306" xml:lang="zh" escape="true">張亞荃</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20240306" xml:lang="zh" escape="true">潘金樹</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核日期</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20240306" xml:lang="zh" escape="true">2024-03-06</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 查核報告</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20240306" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 無保留意見/結論</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20240306" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型細分</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述強調事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述其他事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師查核(核閱)報告內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20240306" xml:lang="zh" escape="true">            會計師查核報告
杏輝藥品工業股份有限公司　公鑒： 
查核意見
杏輝藥品工業股份有限公司及子公司民國112年及111年12月31日之合併資產負債
表，暨民國112年及111年1月1日至12月31日之合併綜合損益表、合併權益變動表，以
及合併現金流量表(包括重大會計政策彙總)，業經本會計師查核竣事。
依本會計師之意見，上開合併財務報告在所有重大方面係依照證券發行人財務報告編
製準則暨經金融監督管理委員會認可並發布生效之國際財務報導準則、國際會計準
則、解釋及解釋公告編製，足以允當表達杏輝藥品工業股份有限公司及子公司民國112
年及111年12月31日之合併財務狀況，暨民國112年及111年1月1日至12月31日之合併
財務績效及合併現金流量。
查核意見之基礎
本會計師係依照會計師受託查核簽證財務報表規則及審計準則執行查核工作。本會計師於
該等準則下之責任將於會計師查核合併財務報告之責任段進一步說明。本會計師所隸
屬事務所受獨立性規範之人員已依會計師職業道德規範，與杏輝藥品工業股份有限公
司及子公司保持超然獨立，並履行該規範之其他責任。本會計師相信已取得足夠及適
切之查核證據，以作為表示查核意見之基礎。
關鍵查核事項
關鍵查核事項係指依本會計師之專業判斷，對杏輝藥品工業股份有限公司及子公司民
國112年度合併財務報告之查核最為重要之事項。該等事項已於查核合併財務報告整
體及形成查核意見之過程中予以因應，本會計師並不對該等事項單獨表示意見。
茲對杏輝藥品工業股份有限公司及子公司民國112年度合併財務報告之關鍵查核事項
敘明如下：
現金及約當現金
截至民國112年12月31日止，合併資產負債表之現金及約當現金為1,074,489仟元，佔
合併資產總額17%。因杏輝藥品工業股份有限公司及子公司相關新藥產品仍在研發階
段，故需維持較高之現金及約當現金餘額以支應未來相關研發成本。惟因現金及約當
現金屬高風險性項目，故列為關鍵查核事項之一。
因應之查核程序
本會計師對上述關鍵查核事項執行主要查核程序如下：
1.評估現金及約當現金相關內部控制制度之設計及執行是否適當，並抽盤庫存現金及核對
銀行對帳單與帳列金額，且依審計準則505號規定向銀行發函詢證。
2.抽查現金及銀行存款鉅額收支之原始憑證，並注意資產負債表日前後現金及銀行存款之
變動情形。
存貨之評價
有關存貨評價之會計政策及其會計估計、假設不確定性請參閱合併財務報告附註四
(八)及附註五(二)。
關鍵查核事項之說明：
杏輝藥品工業股份有限公司及子公司主要營業項目為各式藥品及保健食品之製造與
銷售。由於製藥產業受法規制度之限制成本增加，銷售價格受健保給付制度之影響使
藥品價格調升不易；保健食品受市場價格競爭及廣告推銷投入效益等因素導致存貨售
價可能產生波動。管理階層評估存貨之淨變現價值涉及重大判斷，因此本會計師將存
貨之評價列為關鍵查核事項之一。
因應之查核程序
本會計師對上述關鍵查核事項執行主要查核程序如下：
1.瞭解及評估存貨內部控制制度之設計及執行有效性。
2.進行存貨抽盤，確認並評估存貨是否存在過時或損毀之情事。
3.取得存貨庫齡報表分析存貨庫齡變化情形，並抽核存貨異動之紀錄，驗證所採用存貨庫
齡資料之正確性。
4.評估其存貨提列跌價或呆滯提列政策之合理性，抽核最近存貨銷售價格以評估存貨淨變
現價值之合理性。
5.取得存貨後續衡量之評估文件，評估是否已按既定之會計政策衡量，並檢視管理階層針
對有關存貨衡量之揭露是否允當。
收入之認列
有關收入認列之會計政策及其會計估計、假設不確定性請參閱合併財務報告附註四
(十七)及附註五(二)。
關鍵查核事項之說明：
杏輝藥品工業股份有限公司及子公司部分產品基於銷貨合約條款提供產品折讓或年
度銷貨獎勵，管理階層收入認列衡量時已扣除相關合約折讓及獎勵採淨額認列，因此
本會計師將收入之認列列為關鍵查核事項之一。
因應之查核程序
本會計師對上述關鍵查核事項執行主要查核程序如下：
1.評估收入認列內部控制制度之設計及執行有效性。
2.抽核銷售合約以驗證銷貨收入認列紀錄與合約條件是否相符，並評估管理階層估列之銷
售折讓及銷貨獎勵金額之允當性。
3.評估管理階層針對銷售折讓或銷貨獎勵之會計處理及揭露是否允當。
無形資產之減損
有關無形資產減損之會計政策請詳合併財務報告附註四(十三)非金融資產減損；無形
資產減損評估之重要會計估計及假設，請詳合併務報告附註五(二)。
關鍵查核事項說明：
截至民國112年12月31日止，合併資產負債表之無形資產為71,823仟元，佔合併資產
總額1%。杏輝藥品工業股份有限公司及子公司之無形資產主要係「帶正電荷微脂體
EndoTag-1抗腫瘤藥物新藥」之專利技術授權，未來仍將持續依據此專利技術開發各
項新藥。由於相關新藥仍在研發階段尚未有現金流入，故杏輝藥品工業股份有限公司
及子公司於資產負債表日依據外部及內部資料評估該項資產是否有減損跡象。若有減
損跡象存在，則需評估該資產之可回收金額，確認該無形資產是否有減損。由於減損
評估涉及各項資訊之考量與判斷，又評估結果將直接影響減損損失認列之金額，故列
為關鍵查核事項。
因應之查核程序
本會計師對上述關鍵查核事項執行主要查核程序如下：
1.取得杏輝藥品工業股份有限公司及子公司自行評估資產減損之相關資料，就相關資料與
管理階層討論，並評估下列事項：
(1)研發專案之產品特性、目標市場、技術趨勢及可能衍生之新產品，以確認專利技術
授權仍具市場競爭力。
(2)研發專案進度未有重大之延遲。
(3)資產負債表日公司之總市值高於帳列淨資產之金額。
2.評估杏輝藥品工業股份有限公司及子公司管理階層辨識減損跡象之合理性，及其所使用
之假設及敏感性分析等，包括現金產生單位之區分、現金流量預測、上市機率及折現率等
是否適當。
其他事項
杏輝藥品工業股份有限公司業已編製民國112年及111年度之個體財務報告，並經本會
計師出具無保留意見之查核報告在案，備供參考。
管理階層與治理單位對合併財務報告之責任
管理階層之責任係依照證券發行人財務報告編製準則暨經金融監督管理委員會認可
並發布生效之國際財務報導準則、國際會計準則、解釋及解釋公告編製允當表達之合
併財務報告，且維持與合併財務報告編製有關之必要內部控制，以確保合併財務報告
未存有導因於舞弊或錯誤之重大不實表達。
於編製合併財務報告時，管理階層之責任亦包括評估杏輝藥品工業股份有限公司及子
公司繼續經營之能力、相關事項之揭露，以及繼續經營會計基礎之採用，除非管理階
層意圖清算杏輝藥品工業股份有限公司及子公司或停止營業，或除清算或停業外別無
實際可行之其他方案。
杏輝藥品工業股份有限公司及子公司之治理單位(含審計委員會)負有監督財務報導
流程之責任。
會計師查核合併財務報告之責任
本會計師查核合併財務報告之目的，係對合併財務報告整體是否存有導因於舞弊或錯
誤之重大不實表達取得合理確信，並出具查核報告。合理確信係高度確信，惟依照審
計準則執行之查核工作無法保證必能偵出合併財務報告存有重大不實表達。不實表達
可能導因於舞弊或錯誤。如不實表達之個別金額或彙總數可合理預期將影響合併財務
報告使用者之經濟決策，則被認為具有重大性。
本會計師依照審計準則查核時，運用專業判斷及專業懷疑。本會計師亦執行下列工作:
1.辨認並評估合併財務報告導因於舞弊或錯誤之重大不實表達風險；對所評估之風險設計
及執行適當之因應對策；並取得足夠及適切之查核證據以作為查核意見之基礎。因舞弊可
能涉及共謀、偽造、故意遺漏、不實聲明或踰越內部控制，故未偵出導因於舞弊之重大不
實表達之風險高於導因於錯誤者。
2.對與查核攸關之內部控制取得必要之瞭解，以設計當時情況下適當之查核程序，惟其目
的非對杏輝藥品工業股份有限公司及子公司內部控制之有效性表示意見。
3.評估管理階層所採用會計政策之適當性，及其所作會計估計與相關揭露之合理性。
4.依據所取得之查核證據，對管理階層採用繼續經營會計基礎之適當性，以及使杏輝藥品
工業股份有限公司及子公司繼續經營之能力可能產生重大疑慮之事件或情況是否存在重
大不確定性，作出結論。本會計師若認為該等事件或情況存在重大不確定性，則須於查核
報告中提醒合併財務報告使用者注意合併財務報告之相關揭露，或於該等揭露係屬不適當
時修正查核意見。本會計師之結論係以截至查核報告日所取得之查核證據為基礎。惟未來
事件或情況可能導致杏輝藥品工業股份有限公司及子公司不再具有繼續經營之能力。

5.評估合併財務報告(包括相關附註)之整體表達、結構及內容，以及合併財務報告是否允
當表達相關交易及事件。
6.對於集團內組成個體之財務資訊取得足夠及適切之查核證據，以對合併財務報告表示意
見。本會計師負責集團查核案件之指導、監督及執行，並負責形成集團查核意見。
本會計師與治理單位溝通之事項，包括所規劃之查核範圍及時間，以及重大查核發現
（包括於查核過程中所辨認之內部控制顯著缺失）。 
本會計師亦向治理單位提供本會計師所隸屬事務所受獨立性規範之人員已遵循會計
師職業道德規範中有關獨立性之聲明，並與治理單位溝通所有可能被認為會影響會計
師獨立性之關係及其他事項(包括相關防護措施)。
本會計師從與治理單位溝通之事項中，決定對杏輝藥品工業股份有限公司及子公司民
國112年度合併財務報告查核之關鍵查核事項。本會計師於查核報告中敘明該等事
項，除非法令不允許公開揭露特定事項，或在極罕見情況下，本會計師決定不於查核
報告中溝通特定事項，因可合理預期此溝通所產生之負面影響大於所增進之公眾利
益。
          






	國 富 浩 華 聯 合 會 計 師 事 務 所
	
	會 計 師：張亞荃
	
	會 計 師：潘金樹
	
	核 准 文 號：金管證審字第1050001113號
	核 准 文 號：金管證審字第1070119801號
	民 國 113 年 3 月 6 日




</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司營業收入淨額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司綜合損益金額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>

			<br />
			<span class="zh">
			<div class="title">財務報表附註</div>
			<div id="HistoryAndOrganization">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">公司沿革及業務範圍</th>
					</tr> 
					<tr>
						<td>　 公司沿革及業務範圍</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:HistoryAndOrganization" contextRef="From20230101To20231231" escape="true">
杏輝藥品工業股份有限公司(以下簡稱本公司)於66年7月2日依公司法及有關法
令設立，主要係從事各種西藥、中藥、藥用化妝品、營養品、清潔液之製造、加
工及買賣等業務。本公司及本公司之子公司(以下簡稱合併公司)之主要營運活動，
請參閱附註四(三)之說明。另本公司並無最終母公司。
本合併財務報告係以本公司之功能性貨幣新台幣表達。


</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">通過財報之日期及程序</th>
					</tr> 
					<tr>
						<td>　 通過財報之日期及程序</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DateAndProceduresOfAuthorisationForIssueOfFinancialStatements" contextRef="From20230101To20231231" escape="true">
本合併財務報告已於113年3月6日經董事會通過發布。




</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">新發布及修訂準則及解釋之適用</th>
					</tr> 
					<tr>
						<td>　 新發布及修訂準則及解釋之適用</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations" contextRef="From20230101To20231231" escape="true">
(一)已採用金融監督管理委員會(以下簡稱「金管會」)認可並發布生效之國際財務報導準則、國際會計準則、
解釋及解釋公告(以下簡稱「IFRSs」)之影響：
下表彙列金管會認可之112年度適用之國際財務報導準則之新發布、修正及
修訂之準則及解釋：
新發布/修正/修訂準則及解釋		IASB 發布之生效日
IAS 1之修正「會計政策之揭露」		2023年1月1日（註1）
IAS 8之修正「會計估計值之定義」		2023年1月1日（註2）
IAS 12之修正「與單一交易產生之資產
    及負債有關之遞延所得稅」		2023年1月1日（註3）
IAS 12之修正「國際租稅變革─支柱二規則範本」	    （註4）
註1：於2023年1月1日以後開始之年度報導期間適用此項修正。
註2：於2023年1月1日以後開始之年度報導期間所發生之會計估計值變動及
會計政策變動適用此項修正。
註3：除與租賃及除役義務有關之暫時性差異另有額外規定外，所表達之最早比
較期間開始日（111年1月1日）以後發生之交易適用此項修正。
註4：對於作為IAS 12之暫時性例外規定（亦即企業不得認列有關支柱二所得
稅之遞延所得稅資產及負債，亦不得揭露其相關資訊；惟企業應於財務報告揭露
其已適用此一例外規定），於此修正發布（112年5月23日）後應立即依IAS 8
追溯適用。對於其他揭露規定則適用於2023年1月1日以後開始之年度報導期
間；報導結束日在2023年12月31日以前之期中報導無須揭露該等其他資訊。

1.IAS 1之修正「會計政策之揭露」
此修正闡明，當一項交易、其他事項或情況之規模或性質重大，且與其相
關之會計政策資訊對財務報告而言亦屬重大時，應揭露該等相關之重大會
計政策資訊。反之，若企業判定一項交易、其他事項或情況之規模或性質
並不重大或雖重大但與其相關之會計政策資訊並不重大，則無須揭露該等
不重大之會計政策資訊，惟企業作成會計政策資訊係不重大之結論並不影
響其他IFRS準則所規定之相關揭露。
2.IAS 8之修正「會計估計值之定義」
此修正將會計估計值定義為財務報表中受衡量不確定性影響之貨幣金
額，並提供進一步說明，除導因於前期錯誤更正外，輸入值或衡量技術變
動對會計估計值之影響係屬會計估計值變動。
3.IAS 12之修正「與單一交易產生之資產及負債有關之遞延所得稅」
此修正限縮IAS 12 第15及24段中遞延所得稅負債及資產之認列豁免範
圍。若單一交易於原始認列時產生之應課稅暫時性差異與可減除暫時性差
異之金額相同，則不適用前述豁免規定。企業於第一次適用此修正時，應
於所表達之最早比較期間開始日（111年1月1日），對與租賃及除役義
務有關之所有暫時性差異認列遞延所得稅，並於該日將累計影響數認列為
保留盈餘（或權益之其他組成部分，如適當時）初始餘額之調整。自111
年1月1日以後發生之其他交易則應推延適用此修正。
4.IAS 12之修正「國際租稅變革—支柱二規則範本」
此修正規定，作為IAS 12之暫時性例外規定，企業不得認列與國際租稅
變革有關之支柱二所得稅之遞延所得稅資產及負債，亦不得揭露其相關資
訊；惟企業應於財務報告揭露其已適用此一例外規定。此外，企業應單獨
揭露有關支柱二所得稅之當期所得稅費用（利益）。若支柱二法案已立法
或已實質性立法但尚未生效，企業應揭露其暴露於支柱二所得稅之已知或
可合理估計之質性及量化資訊。
經評估上述準則及解釋對合併公司財務狀況與財務績效並無重大影響。
(二)尚未採用經金管會認可之新發布、修正後國際財務報導準則之影響：
下表彙列金管會認可之113年適用之國際財務報導準則之新發布、修正及修訂
之準則及解釋：
新發布/修正/修訂準則及解釋		        IASB 發布之生效日
IFRS16之修正「售後租回中之租賃負債」		2024年1月1日（註1）
IAS 1之修正「負債分類為流動或非流動」		2024年1月1日
IAS 1之修正「具合約條款之非流動負債」		2024年1月1日
IAS 7及IFRS 7之修正「供應商融資安排」		2024年1月1日（註2）
註1：賣方兼承租人應將本修正之內容，依IAS 8之規定追溯適用於初次適用IFRS 
16之日後所簽定之售後租回交易。
註2：本修正提供某些過渡放寬規定，於首次適用時，企業無須揭露比較資訊及
期中期間資訊，以及第44H段(b)(ii)-(iii)所規定之期初資訊。
1.IFRS 16之修正「售後租回中之租賃負債」
　　此修正闡明，對於售後租回之交易，若資產之移轉依IFRS 15之規定係以
銷售處理者，賣方兼承租人因租回所產生之負債應依IFRS 16有關租賃負債之
規定處理；惟若涉及非取決於指數或費率之變動租賃給付時，賣方兼承租人仍
應以不認列與所保留使用權有關之損益之方式決定並認列該等變動給付所產
生之租賃負債，後續實際之租賃給付金額與減少之租賃負債帳面金額間之差額
係認列於損益。
2.IAS 1之修正「負債分類為流動或非流動」
　　此修正闡明，判斷負債是否分類為非流動時，應評估企業於報導期間結束
日是否具有遞延清償期限至報導期間後至少12個月之權利。若企業於報導期間
結束日具有該權利，則無論企業是否預期將行使該權利，該負債應分類為非流
動。若企業必須遵循特定條件始具有將清償遞延之權利，則必須於報導期間結
束日已遵循該等特定條件，始能將該負債分類為非流動，即使債權人係於較晚
日期檢測企業是否遵循該等條件。
　　此外，此修正規定，為負債分類之目的，前述清償係指移轉現金、其他經
濟資源或本集團之權益工具予交易對方致負債之消滅。惟若負債之條款，可能
依交易對方之選擇，以移轉本集團之權益工具而導致其清償，且若該選擇權依
IAS 32「金融工具：表達」之規定係單獨認列於權益，則前述條款並不影響負
債之分類。
3.IAS 1之修正「具合約條款之非流動負債」
　　此修正進一步闡明，僅有報導期間結束日以前須遵循之合約條款會影響該
日負債之分類。報導期間後12個月內須遵循之合約條款並不影響負債之分類，
惟企業對於報導期間結束日分類為非流動負債，若可能無法遵循合約條款而須
於報導期間後12個月內清償者，應於附註揭露相關事實及情況。
4.IAS 7及IFRS 7之修正「供應商融資安排」
　　供應商融資安排係由一個或多個融資提供者代企業支付帳款予供應商，而
企業同意依據與供應商約定之付款日或較晚之日期付款予融資提供者。IAS 7之
修正係規定企業應揭露其供應商融資安排之資訊，以使財務報表使用者能夠評估
該等安排對企業之負債、現金流量及流動性風險暴險之影響。IFRS 7之修正則於
其應用指引中，納入企業於揭露如何管理金融負債流動性風險時，亦可能考量其
是否透過供應商融資安排已取得或可取得融資額度，以及該等安排是否可能導致
流動性風險集中之情況。
經評估上述準則及解釋對合併公司財務狀況與財務績效並無重大影響。
(三)國際會計準則理事會已發布但尚未經金管會認可之國際財務報導準則之影響：
下表彙列國際會計準則理事會已發布但尚未納入金管會認可之國際財務報導
準則之新發布、修正及修訂之準則及解釋：
新發布/修正/修訂準則及解釋		IASB 發布之生效日
IFRS 10及IAS 28之修正「投資者與其關聯
企業或合資間之資產出售或投入」		未定
IFRS 17「保險合約」		        2023年1月1日
IFRS 17之修正		                2023年1月1日
IFRS 17之修正「初次適用IFRS 17及
IFRS 9-比較資訊」		        2023年1月1日
IAS 21之修正「缺乏可兌換性」		2025年1月1日
截至本合併財務報告發布日止，合併公司仍持續評估上述準則及解釋對合併
公司財務狀況與財務績效之影響，相關影響待評估完成時予以揭露。





</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SummaryOfSignificantAccountingPolicies">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計政策之彙總說明</th>
					</tr> 
					<tr>
						<td>　 遵循聲明</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:StatementOfIFRSAndRelatedRegulationsCompliance" contextRef="From20230101To20231231" escape="true">
編製本合併財務報告所採用之主要會計政策說明如下，除另有說明外，此等政策
在所有報導期間內一致適用。
(一)遵循聲明
本合併財務報告係依據證券發行人財務報告編製準則編製與金管會認可並
發布生效之國際財務報導準則、國際會計準則、解釋及解釋公告(以下簡稱
IFRSs)編製。


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 編製基礎</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BasisOfPreparation" contextRef="From20230101To20231231" escape="true">
1.除下列重要項目外，本合併財務報告係按歷史成本編製：
(1) 按公允價值衡量之透過損益按公允價值衡量之金融資產及負債(包括衍生
工具)。
(2) 按公允價值衡量之透過其他綜合損益按公允價值衡量之金融資產。
(3) 按退休基金資產減除確定福利義務現值之淨額認列之確定福利負債。
2.編製符合金管會認可之IFRSs 財務報告需要使用一些重要會計估計，在應用合
併公司的會計政策過程中亦需要管理階層運用其判斷，涉及高度判斷或複雜性之
項目，或涉及合併財務報告之重大假設及估計之項目，請詳附註五說明。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 合併報表編製原則</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PrinciplesOfConsolidation" contextRef="From20230101To20231231" escape="true">
1.合併財務報告編製原則:
(1)合併公司將所有子公司納入合併財務報告編製之個體。子公司指受合併公司
控制之個體，當合併公司暴露於來自對該個體參與之變動報酬或對該等變動報
酬享有權利，且透過對該個體之權力有能力影響該等報酬時，合併公司即控制
該個體。子公司自合併公司取得控制之日起納入合併財務報告，於喪失控制之
日起終止合併。
(2)合併公司間之交易、餘額及未實現損益業已銷除。子公司之會計政策已作必
要之調整，與合併公司採用之政策一致。
(3)損益及其他綜合損益各組成部分歸屬於母公司業主及非控制權益；綜合損益
總額亦歸屬於母公司業主及非控制權益，即使因而導致非控制權益發生虧損餘
額。
(4)對子公司持股之變動若未導致喪失控制(與非控制權益之交易)，係作為權益
交易處理，亦即視為與業主間進行之交易。非控制權益之調整金額與所支付或
收取對價之公允價值間之差額直接認列為權益。
(5)當合併公司喪失對子公司之控制，對前子公司之剩餘投資係按公允價值重新
衡量，並作為原始認列金融資產之公允價值或原始認列投資關聯企業或合資之
成本，公允價值與帳面金額之差額認列為當期損益。對於先前認列於其他綜合
損益與該子公司有關之所有金額，其會計處理與合併公司若直接處分相關資產
或負債之基礎相同，亦即如先前認列為其他綜合損益之利益或損失，於處分相
關資產或負債時將被重分類為損益，則當喪失對子公司之控制時，將該利益或
損失自權益重分類為損益。
2.列入合併財務報告之子公司如下：
						                                                      持股或出資比例
投資公司名稱		        子公司名稱		主要營業項目	                       112年12月31日	111年12月31日	
本公司		                CANCAP PHARMACEUTICAL LTD.		健康食品之製造及銷售	      88.43%	 88.43%	
本公司		                SUNETIC BIOTECH INC.		        投資事業		      83.47%	 83.47%	
本公司		                UNIVERSAL NEXT TECHNOLOGIES INC.	投資事業		     100.00%	100.00%	
本公司		                杏力醫療器材生技股份有限公司	        醫療包材之製造及銷售	     100.00%	100.00%	
本公司		                杏國新藥股份有限公司		        新藥及生物技術服務業	      64.26% (註) 62.09%                                                                                   (註)	      62.09%	
杏國新藥股份有限公司	        SynCore BiotechnologyEurope GmbH        新藥研發及生物技術服務業     100.00%	100.00%	
SUNETIC BIOTECH INC.	        杏輝天力(杭州)藥業有限公司		原料、藥劑等之產銷業務	     100.00%	100.00%	
杏輝天力(杭州)藥業有限公司	和田天力沙生藥物開發有限責任公司	沙生藥物之科學研究及產銷業務  91.00%	91.00%	
杏輝天力(杭州)藥業有限公司	杭州維存保健食品有限公司		健康食品及化妝品之銷售	     100.00%	100.00%	
註：(1)子公司杏國新藥股份有限公司於112年5月5日經股東常會決議通過辦理減
資彌補虧損，減資金額為843,325仟元，銷除股份84,332仟股(含私募普通股33,131
仟股)，減資比率73.28%，並已於民國112年5月31日完成變更登記。
(2)子公司杏國新藥股份有限公司於112年8月8日經董事會決議通過辦理現
金增資發行普通股4,420仟股，現金增資發行價格為每股新台幣34元溢價發
行，募集資金總額為150,280仟元該項增資業已辦妥變更登記在案，合併公司取得本次增資發行
之股數為3,507仟股。
3.未列入合併財務報告之子公司：無。
4.子公司會計期間不同之調整及處理方式：無。
5.重大限制：無。
6.子公司持有母公司發行證券之內容：無。
7.具重大非控制權益之子公司資訊：

			                                   非控制權益所持股權及表決權比例
子公司名稱		      主要營業場所		112年12月31日	 	111年12月31日
杏國新藥股份有限公司		台灣		          35.74%		 37.91%
SUNETIC BIOTECH INC.		模里西斯		  16.53%		 16.53%
		
                                   分配予非控制權益之損益	
子公司名稱		           112年度			 111年度	
杏國新藥股份有限公司		    $(15,474)			$(71,516)	
SUNETIC BIOTECH INC.		      (2,603)			  12,123 	
(不含子公司之非控制權益)								
其他			                (317)			　(1,077)	
合　　計	        	$    (18,394)			$(60,470)	

                                   非控制權益	
子公司名稱		          112年12月31日			111年12月31日	
杏國新藥股份有限公司		$ 	127,816 		$ 	94,585	
SUNETIC BIOTECH INC.			161,510				181,325	
(不含子公司之非控制權益)								
其他			                 10,210				10,708	
合　　計		       $	299,536			$	286,618	
								
上列子公司主要營業場所及註冊之國家資訊請參閱附註十三附表四。
各子公司之彙總性財務資訊以公司間交易銷除前之金額列示如下：

(1)資產負債表
                                 杏國新藥股份有限公司及子公司	
項 目		                  112年12月31日		111年12月31日	
流動資產		$ 	310,481 		$ 	348,233 	
非流動資產			67,881 			         88,415 	
流動負債			(21,226)			(186,644)	
非流動負債			- 			           (992)	
權　　益		$ 	357,136 		$ 	249,012 	
權益歸屬於：							
　本公司權益(註1)	$ 	229,834 		$ 	154,941 	
  非控制權益			127,816 			94,585 	
  IFRS16首次適用調整(註2)	(514)			          (514)	
		        $ 	357,136 		$ 	249,012 	
註1：112年及111年12月31日其中分別有533仟元及522仟元係子公司
承租房屋及建築等，認列損益之時間差異，此屬合併公司間之交易，於合併
報告編製時，業已全數消除。
註2：係向母公司承租之房屋及建築，於首次適用IFRS16時，產生之累積
影響數，此屬合併公司間之交易，於合併報告編製時，業已全數消除。		
				
                             SUNETIC BIOTECH INC.及子公司
項 目		           112年12月31日		111年12月31日
流動資產		$ 	328,714 		$ 	418,420 
非流動資產			748,483 			780,983 
流動負債			(39,368)			(62,780)
非流動負債			(18,521)			(22,343)
權　　益		$ 	1,019,308 		$ 	1,114,280 
權益歸屬於：						
　本公司權益		$	842,572 		$ 	921,424 
　非控制權益			166,855 			182,472 
    子公司之非控制權益		  9,881 			10,384 
		        $ 	1,019,308 		$ 	1,114,280 

(2)綜合損益表
                                 杏國新藥股份有限公司及子公司
項 目	　	                112年度		      111年度
營業收入		$	20,196 		    $	15,857 
本期淨損		$	(38,172)	    $	(188,666)
其他綜合損益			(2,984)	 		(5,242)
綜合損益總額		$	(41,156)	    $	(193,908)
淨損歸屬於：						
　　本公司權益(註)	$	(22,698)	    $	(117,150)
    非控制權益			(15,474)	         (71,516)
         		$	(38,172)	    $	(188,666)
綜合損益總額歸屬於：						
　　本公司權益(註)	$	(24,543)	    $	(120,406)
    非控制權益			(16,613)		(73,502)
		        $	(41,156)	    $	(193,908)
註：112年及111年度其中分別有11仟元及102仟元係子公司承租房屋及建
築等，認列損益之時間差異，此屬合併公司間之交易，於合併報告編製時，
業已全數消除。


                                  SUNETIC BIOTECH INC.及子公司
項 目	　	                  112年度		111年度
營業收入		$	243,995 	$       328,520 
本期淨利		$	9,648 		$	71,464 
非控制權益淨損			(317)			(1,077)
本期淨利			9,331 			70,387 
其他綜合損益			(18,254)	  	16,839 
綜合損益總額		$	(8,923)	  	$	87,226 
淨利(損)歸屬於：						
　　本公司權益		$	8,053 		$	59,651 
    非控制權益			1,595 			11,813 
      子公司之非控制權益	(317)			(1,077)
		       $	9,331 		$	70,387 
綜合損益總額歸屬於：						
　　本公司權益		$	(7,028)	  	$	73,565 
    非控制權益			(1,392)	  		14,568 
      子公司之非控制權益	(503)			(907)
		       $	(8,923)	  	$	87,226 

(3)現金流量表
                                  杏國新藥股份有限公司及子公司
項 目		                112年度		       111年度
營業活動		$ 	(82,373)	  	$ (209,612)
投資活動			(778)	  	 	(1,031)
籌資活動			78,675 			(73,212)
匯率變動之影響			27 	  		30 
　淨現金流出		$ 	(4,449)	  	      $ (283,825)
支付予非控制權益之股利	$ 	-		      $    - 

                                    SUNETIC BIOTECH INC.及子公司
項 目		                  112年度		 111年度
營業活動		$ 	(30,123)		$ 165,768
投資活動			(27,465)	  	   29,329
籌資活動			(86,182)		   (53,197)
匯率變動之影響			(4,271)	 		     5,011
　淨現金流入(出)	$ 	(148,041)		$   146,911
支付予非控制權益之股利	$ 	14,225		        $     8,795








</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='30' rowspan='1' style="text-align:left">列入合併財務報表之子公司</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">子公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">業務性質</th> 
						<th colspan='2' rowspan='1' style="text-align:center">所持股權百分比</th> 
						<th colspan='1' rowspan='2' style="text-align:center">說明</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='1' style="text-align:center">本期</th> 
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th> 
					</tr>
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">CANCAP PHARMACEUTICAL LTD.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">健康食品之製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">88.43</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">88.43</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">SUNETIC BIOTECH INC.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">投資事業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">83.47</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">83.47</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">UNIVERSAL NEXT TECHNOLOGIES INC.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">投資事業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">醫療包材之製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">新藥及生物技術服務業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">64.26</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">62.09</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">SynCore Biotechnology Europe GmbH</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">新藥研發及生物技術服務業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">SUNETIC BIOTECH INC.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">原料、藥劑等之產銷業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">和田天力沙生藥物開發有限責任公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">沙生藥物之科學研究及產銷業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">91.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">91.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">杭州維存保健食品有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">健康食品及化妝品之銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
				</table> 
			<div style="text-align:center">未列入合併財務報表之子公司</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td>　 外幣</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ForeignCurrencies" contextRef="From20230101To20231231" escape="true">
1.外幣交易
外幣交易依交易日之匯率換算為功能性貨幣。資產負債表日之外幣貨幣性
項目依當日之匯率換算為功能性貨幣，其兌換損益係指期初以功能性貨幣
計價之攤銷後成本，調整當期之有效利息及付款後之金額，與依外幣計價
之攤銷後成本按資產負債表日匯率換算金額間之差異。以公允價值衡量之
外幣非貨幣性項目依衡量公允價值當日之匯率重新換算為功能性貨幣，以
歷史成本衡量之外幣非貨幣性項目則依交易日之匯率換算。除屬公允價值
變動列於其他綜合損益者、指定為國外營運機構淨投資避險之金融負債或
合格之現金流量避險，換算所產生之外幣兌換差異認列於其他綜合損益
外，餘認列為當年度損益。
2.國外營運機構
於編製合併財務報告時，合併公司國外營運機構（包含營運所在國家或使
用之貨幣與本公司不同之子公司、關聯企業或分公司）之資產及負債以每
一資產負債表日匯率換算為新台幣。收益及費損項目係以當期平均匯率換
算，所產生之兌換差額列於其他綜合損益，並累計於權益項下之國外營運
機構財務報表換算之兌換差額。
在處分國外營運機構並構成對該國外營運機構喪失控制、聯合控制或重大
影響時，所有與該國外營運機構相關之權益將重分類為損益。
在部分處分包含於國外營運機構之子公司未構成對該子公司喪失控制時，
係按比例將認列於其他綜合損益之累計兌換差額併入權益交易計算，但不
認列為損益。在其他任何部分處分國外營運機構之情況下，認列於其他綜
合損益之累計兌換差額則按處分比例重分類至損益。






</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 資產與負債區分流動與非流動之標準</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfCurrentAndNoncurrentAssetsAndLiabilities" contextRef="From20230101To20231231" escape="true">
1.資產符合下列條件之一者，分類為流動資產：
(1)預期將於正常營業週期中實現該資產，或意圖將其出售或消耗者。
(2)主要為交易目的而持有者。
(3)預期於資產負債表日後十二個月內將實現者。
(4)現金或約當現金，但於資產負債表日後逾十二個月用以交換、清償負債或受
到其他限制者除外。
合併公司將所有不符合上述條件之資產分類為非流動。
2.負債符合下列條件之一者，分類為流動負債：
(1)預期將於正常營業週期中清償者。
(2)主要為交易目的而持有者。
(3)須於資產負債表日後十二個月內清償者（即使於資產負債表日後至通過發布
財務報告前已完成長期性之再融資或重新安排付款協議，亦屬流動負債）。
(4)不能無條件將清償期限延期至資產負債表日後至少十二個月者。負債之條款，
可能依交易對方之選擇，以發行權益工具而導致清償者，不影響其分類。
合併公司將所有不符合上述條件之負債分類為非流動。





</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 現金及約當現金</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CashAndCashEquivalents" contextRef="From20230101To20231231" escape="true">
現金及約當現金包括庫存現金、銀行存款及隨時可轉換成定額現金且價值風
險變動甚小之短期並具高度流動性之投資。原始到期日在一年內之定期存款，
符合前述定義且持有目的係滿足短期現金承諾而非投資或其他目的者，列報
於約當現金。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 金融工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialInstruments" contextRef="From20230101To20231231" escape="true">
金融資產與金融負債於合併公司成為該金融工具合約條款之一方時認列。
金融資產與金融負債原始認列時，係依公允價值衡量。原始認列時，直接可
歸屬於金融資產與金融負債(除分類為透過損益按公允價值衡量之金融資產
及金融負債外)取得或發行之交易成本，應從該金融資產或金融負債公允價
值加計或減除。直接可歸屬於透過損益按公允價值衡量之金融資產及金融
負債之交易成本，則立即認列為損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssets" contextRef="From20230101To20231231" escape="true">

(1)衡量種類
金融資產之慣例交易係採交易日會計認列。
合併公司所持有之金融資產種類為透過損益按公允價值衡量之金融資
產、按攤銷後成本衡量之金融資產與透過其他綜合損益按公允價值衡
量之權益工具投資。


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="From20230101To20231231" escape="true">
A.透過損益按公允價值衡量之金融資產
透過損益按公允價值衡量之金融資產包括強制透過損益按公允價
值衡量及指定為透過損益按公允價值衡量之金融資產。強制透過損
益按公允價值衡量之金融資產包括合併公司未指定透過其他綜合
損益按公允價值衡量之權益工具投資，及不符合分類為按攤銷後成
本衡量或透過其他綜合損益按公允價值衡量之債務工具投資。
透過損益按公允價值衡量之金融資產係按公允價值衡量，其股利、
利息收入及再衡量利益或損失係認列於其他利益及損失。公允價值
之決定方式請參閱附註十二(三)。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過其他綜合損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="From20230101To20231231" escape="true">
B.透過其他綜合損益按公允價值衡量之權益工具投資
合併公司於原始認列時，可作一不可撤銷之選擇，將非持有供交易
且非企業合併收購者所認列或有對價之權益工具投資，指定為透過
其他綜合損益按公允價值衡量。
透過其他綜合損益按公允價值衡量之權益工具投資係按公允價值
衡量，後續公允價值變動列報於其他綜合損益，並累計於其他權益
中。於投資處分時，累積損益直接移轉至保留盈餘，並不重分類為
損益。
透過其他綜合損益按公允價值衡量之權益工具投資之股利於合併
公司收款之權利確立時認列於損益中，除非該股利明顯代表部分投
資成本之回收。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" escape="true">
C.按攤銷後成本衡量之金融資產
合併公司投資金融資產若同時符合下列兩條件，則分類為按攤銷後
成本衡量之金融資產：
(A)係於某經營模式下持有，該模式之目的係持有金融資產以收取合約現
金流量；及
(B)合約條款產生特定日期之現金流量，該等現金流量完全為支付本金及
流通在外本金金額之利息。
按攤銷後成本衡量之金融資產於原始認列後，係以有效利息法決定
之總帳面金額減除任何減損損失之攤銷後成本衡量，任何外幣兌換
損益則認列於損益。
除下列兩種情況外，利息收入係以有效利率乘以金融資產總帳面金額計算：
(A)購入或創始之信用減損金融資產，利息收入係以信用調整後有效利率
乘以金融資產攤銷後成本計算。
(B)非屬購入或創始之信用減損，但後續變成信用減損之金融資產，利息
收入係以有效利率乘以金融資產攤銷後成本計算。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfFinancialAssets" contextRef="From20230101To20231231" escape="true">

(2)金融資產減損
合併公司於每一資產負債表日按預期信用損失評估按攤銷後成本衡量
之金融資產(含應收帳款)減損損失。
應收帳款按存續期間預期信用損失認列備抵損失。其他金融資產係先
評估自原始認列後信用風險是否顯著增加，若未顯著增加，則按12個月預期信用損失認列備抵損失，
若已顯著增加，則按存續期間預期信用損失認列備抵損失。
預期信用損失係以發生違約之風險作為權重之加權平均信用損失。12
個月預期信用損失係代表金融工具於報導日後12個月內可能違約事
項所產生之預期信用損失，存續期間預期信用損失則代表金融工具於
預期存續期間所有可能違約事項產生之預期信用損失。
所有金融資產之減損損失係藉由備抵帳戶調降其帳面金額。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialAssets" contextRef="From20230101To20231231" escape="true">
(3)金融資產之除列
合併公司於符合下列情況之一時，將除列金融資產：
A.來自金融資產現金流量之合約之權利失效。
B.移轉收取金融資產現金流量之合約權利，且業已移轉金融資產所有權之
幾乎所有風險及報酬。
C.既未移轉亦未保留金融資產所有權之幾乎所有風險及報酬，惟未保留對
金融資產之控制。
按攤銷後成本衡量之金融資產整體除列時，其帳面金額與所收取對價
間之差額係認列於損益。透過其他綜合損益按公允價值衡量之權益工
具投資整體除列時，累積損益直接移轉至保留盈餘，並不重分類為損
益。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融負債及權益工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAndEquityInstruments" contextRef="From20230101To20231231" escape="true">
2.金融負債
(1)後續衡量
除下列情況外，所有金融負債係以有效利息法按攤銷後成本衡量


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 負債或權益之分類</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfFinancialLiabilitiesAndEquityInstruments" contextRef="From20230101To20231231" escape="true">
A.透過損益按公允價值衡量之金融負債係指持有供交易之金融負債或原始
認列時被指定為透過損益按公允價值衡量之金融負債。分類為持有供交
易之金融負債係於發生時之主要目的為短期內再買回，及除財務保證合約
或被指定且有效避險工具外之衍生工具。合併公司於金融負債符合下列條
件之一時，於原始認列將其指定為透過損益按公允價值衡量：
(A)係含嵌入式衍生工具之混合(結合)合約，且主合約非屬IFRS 9範圍
內之資產；或
(B)可消除或重大減少衡量或認列不一致；或
(C)係依書面之風險管理政策，以公允價值基礎管理並評估其績效之工
具。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20230101To20231231" escape="true">
B.透過損益按公允價值衡量之金融負債，於原始認列時按公允價值衡量，
相關交易成本則認列為當期損益。續後按公允價值衡量，其公允價值之變
動認列於當期損益。
C.指定為透過損益按公允價值衡量之金融負債，因信用風險變動所產生之
公允價值變動金額係認列於其他綜合損益，後續不予重分類至損益，該負
債剩餘之公允價值變動金額則列報於損益。惟若上述會計處理引發或加劇
會計配比不當，則該負債之利益或損失全數列報於損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 其他金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OtherFinancialLiabilities" contextRef="From20230101To20231231" escape="true">
3.金融工具之修改
　　當金融工具之合約現金流量發生重新協商或修改時，若未導致應除列該金融
工具，則合併公司以修改後之合約現金流量按原始有效利率折現重新計算金融資
產之總帳面金額或金融負債之攤銷後成本，並將修改利益或損失認列於損益；所
發生之成本或收費則作為修改後金融工具帳面金額之調整，並於修改後剩餘期間
攤銷。若該重新協商或修改導致應除列該金融工具時，則依除列規定處理。
利率指標變革導致決定金融工具之合約現金流量基礎之變動，若為利率指標
變革之直接結果所必須，且新基礎在經濟上約當於變動前之基礎，合併公司
採用實務權宜作法，於決定基礎變動時視為有效利率變動。若除利率指標變
革所要求對決定合約現金流量之基礎作變動外，尚對金融工具作額外變動，
合併公司先適用實務權宜作法於利率指標變革所要求之變動，再適用金融工
具修改之規定於不適用實務權宜作法之任何額外變動。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融負債之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialLiabilities" contextRef="From20230101To20231231" escape="true">
(2)金融負債之除列
合併公司僅於義務解除、取消或失效時，始將金融負債除列。除列金
融負債時，其帳面金額與所支付或應支付對價總額(包含任何所移轉之
非現金資產或承擔之負債)之差額認列為損益。


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 存貨</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Inventories" contextRef="From20230101To20231231" escape="true">
存貨按成本與淨變現價值孰低者為衡量基礎，採永續盤存制，成本依加權平
均法決定。製成品及在製品之成本包括原料、直接人工、其他直接成本及生
產相關之製造費用(按正常產能分攤)，惟不包括借款成本。比較成本與淨變
現價值孰低時，採逐項比較法，淨變現價值係指在正常營業過程中之估計售
價減除至完工尚須投入之估計成本及完成出售所需之估計成本後之餘額。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 生物資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BiologicalAssets" contextRef="From20230101To20231231" escape="true">
農業活動係企業對生物資產之生物轉化及收成之管理，以供銷售、轉化為農
產品或轉換為額外之生物資產，生物資產應於原始認列時及每一報導期間結
束日以公允價值減出售成本衡量；當生物資產原始認列時無法取得其市場決
定之價格或價值，且決定公允價值之替代估計顯不可靠之情形，生物資產應
以其成本減所有累計折舊及所有累計減損損失衡量；自生物資產收成之農產
品，應以收成點之公允價值減出售成本衡量。
以公允價值減出售成本原始認列生物資產所產生之利益或損失，以及生物資
產公允價值減出售成本之變動所產生之利益或損失，於發生當期計入損益。
合併公司農業活動為寄生植物管花肉蓯蓉之種植，其主係用來作為合併公司
製成品之原材料




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 不動產（、廠房）及設備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PropertyPlantAndEquipment" contextRef="From20230101To20231231" escape="true">
1.不動產、廠房及設備(包含生產性植物)係以取得成本為入帳基礎，並將購建期
間之有關利息資本化。建造中之不動產、廠房及設備於達預期使用狀態前，測試
該等資產能否正常運作時所生產之樣品係以成本與淨變現價值孰低衡量，其銷售
價款及成本係認列於損益。
2.後續成本只有在與該項目有關之未來經濟效益很有可能流入合併公司，且該項
目之成本能可靠衡量時，才包括在資產之帳面金額或認列為一項單獨資產。被重
置部分之帳面金額應除列。所有其他維修費用於發生時認列為當期損益。
3.土地不提列折舊，其他不動產、廠房及設備採成本模式，按估計耐用年限以直
線法計提折舊。合併公司於每一財務年度結束日對各項資產之殘值、耐用年限及
折舊方法進行檢視，若殘值及耐用年限之預期值與先前之估計不同時，或資產所
含之未來經濟效益之預期消耗型態已有重大變動，則自變動發生日起依國際會計
準則第8號「會計政策、會計估計變動及錯誤」之會計估計變動規定處理。各項
資產之耐用年限如下：
房屋及建築	3∼55年
機器設備	1∼18年
運輸設備	2∼10年
辦公設備	1∼15年
其他設備(包含生產性植物)     1∼10年
4.於處分或預期無法由使用或處分產生未來經濟效益時，將不動產、廠房及設備
除列。除列不動產、廠房及設備所產生之利益或損失金額，係淨處分價款與該資
產帳面金額間差額，並且認列於當期損益。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 租賃</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Leasing" contextRef="From20230101To20231231" escape="true">
合併公司係於合約成立日評估合約是否係屬（或包含）租賃。對於合約包含
一項租賃組成部分以及一項或多項之額外租賃或非租賃組成部分者，合併公
司以每一租賃組成部分之相對單獨價格及非租賃組成部分之彙總單獨價格
為基礎，將合約中之對價分攤至該租賃組成部分。
1.合併公司為承租人
除低價值標的資產之租賃及短期租賃按直線基礎認列費用外，合併公司對
其他租賃皆於租賃開始日認列使用權資產及租賃負債。
使用權資產
使用權資產原始按成本(包含租賃負債之原始衡量金額、租賃開始日前支付
之租賃給付減除收取之租賃誘因、原始直接成本及復原標的資產之估計成
本)衡量，後續按成本減除累計折舊及累計減損損失後之金額衡量，並調整
租賃負債之再衡量數。
使用權資產係以單行項目列報於合併資產負債表。
使用權資產採直線基礎自租賃開始日起至耐用年限屆滿時或租賃期間屆滿
時兩者之較早者提列折舊，惟若租賃期間屆滿時將取得標的資產所有權，
或若使用權資產之成本反映購買選擇權之行使，則自租賃開始日起至標的
資產耐用年限屆滿時提列折舊。
2.合併公司為出租人
租賃如移轉附屬於標的資產所有權之幾乎所有風險與報酬，則分類為融資
租賃；反之，則分類為營業租賃。








</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 無形資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IntangibleAssets" contextRef="From20230101To20231231" escape="true">
1.非內部產生之無形資產-確定耐用年限
政府捐助所取得之無形資產按公平價值認列，無形資產原始認列時以取得
成本衡量。後續以成本減除累計攤銷及累計減損損失後之金額作為帳面價
值。無形資產依估計耐用年限攤銷方式如下：
(1)電腦軟體成本：按1∼10年以直線法攤銷。
(2)專門技術：按10∼20年以直線法攤銷。
(3)授權金：按專利權註冊之法定年限或合約年限孰短者，以直線法攤銷。
每年至少於財務年度結束日時檢視無形資產之殘值、攤銷期間及攤銷方法，
若有變動，則推延適用會計估計變動。
2.內部產生之無形資產-研究與發展-非確定耐用年限
(1)研究階段之支出除於企業合併認列為商譽或無形資產者外，於發生時即認列
為費用。
(2)合併公司於同時符合下列條件時，開始認列內部計畫發展階段之無形資產： 
A.已完成該無形資產之技術可行性，將使該無形資產可供使用或出售。 
B.意圖完成該無形資產，並加以使用或出售。 
C.有能力使用或出售該無形資產。
D.無形資產很有可能產生未來之經濟效益。
E.具充足之技術、財務及其他資源完成此項發展計畫，並使用或出售該無形
資產。
F.歸屬於該無形資產發展階段之支出，能可靠衡量。
(3)已資本化之發展階段無形資產，以成本減除累計攤銷及累計減損損失後之金
額作為帳面價值。屬非確定耐用年限之無形資產不得攤銷。
(4)每年於資產負債表日評估是否有事件及情況繼續證明非確定耐用年限無形
資產之耐用年限仍屬非確定。耐用年限由非確定改為有限時，視為會計估計變
動。
3.除列
除列無形資產所產生之利益或損失金額，係淨處分價款與該資產帳面金額
間之差額，並且認列於當期損益








</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 非金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfNonFinancialAsset" contextRef="From20230101To20231231" escape="true">
合併公司於資產負債表日針對有減損跡象之資產，估計其可回收金額，當可
回收金額低於其帳面價值時，則認列減損損失。可回收金額係指一項資產之
公允價值減處分成本或其使用價值，兩者較高者。當以前年度認列資產減損
之情況不存在時，則在以前年度提列損失金額之範圍內予以迴轉。
商譽、非確定耐用年限無形資產及尚未可供使用無形資產，應定期估計其可
回收金額。當可回收金額低於其帳面價值時，則認列減損損失。商譽減損之
減損損失於以後年度不得迴轉。


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 負債準備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Provisions" contextRef="From20230101To20231231" escape="true">
負債準備係因過去事件而負有現時法定或推定義務，很有可能需要流出具經
濟效益之資源以清償該義務，且該義務之金額能可靠估計時認列。負債準備
之衡量係以資產負債表日清償該義務所需支出之最佳估計現值衡量，折現率
採用反映目前市場對貨幣時間價值及負債特定風險之評估之稅前折現率，折
現之攤銷認列為利息費用。未來營運損失不得認列負債準備。





</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 收入之認列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:RevenueRecognition" contextRef="From20230101To20231231" escape="true">
合併公司於客戶合約辨認履約義務後，將交易價格分攤至各履約義務，並於
滿足各履約義務時認列收入。
1.商品銷貨收入
產品於運抵客戶指定地點時或起運時，客戶對商品已有訂定價格與使用之
權利且負有再銷售之主要責任，並承擔商品陳舊過時風險，合併公司係於
該時點認列收入及應收帳款。銷售之預收款項，於產品運抵前係認列為合
約負債。
2.授權收入
銷售授權金因屬取用存在於授權期間之企業智慧財產權之權利，收取之權
利金係隨時間經過逐步認列授權收入。
3.技術服務收入
合併公司提供研發技術試驗之相關服務。勞務收入於服務提供予客戶之期
間內認列為收入。客戶依照合約付款時間表所支付價款，當合併公司已提
供之服務超過客戶應付款時認列為合約資產；若客戶已付款項超過合併公
司已提供之服務時，則認列為合約負債。
合併公司對收入、成本及完工程度之估計隨試驗情況進行修正，任何導因
於估計變動之收入、成本增減等，於修正情況為管理階層所知悉之期間內
反映於損益。







</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 借款成本</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BorrowingCost" contextRef="From20230101To20231231" escape="true">
直接可歸屬於取得、建造或生產符合要件之資產之借款成本，係作為該資產
成本之一部分，直到該資產達到預定使用或出售狀態之幾乎所有必要活動已
完成為止。
特定借款如於符合要件之資本支出發生前進行暫時投資而賺取之投資收入，
係自符合資本化條件之借款成本中減除。
除上述外，所有其他借款成本係於發生當期認列為損益。




</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 政府補助</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:GovernmentGrants" contextRef="From20230101To20231231" escape="true">
政府補助於可合理確信企業將遵循政府補助所附加之條件，且將可收到該項
補助時，按公允價值予以認列。
政府補助係於其意圖補償之相關成本於合併公司認列為費用之期間內，按有
系統之基礎認列於損益。若政府補助係用於補償已發生之費用或損失，或係
以給與合併公司立即財務支援為目的且無未來相關成本，則於其可收取之期
間認列於損益。與不動產、廠房及設備有關之政府補助，做為該資產帳面價
值之減項，於資產耐用年限內透過折舊費用之減少將補助認列於損益。





</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 員工福利</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:EmployeeBenefits" contextRef="From20230101To20231231" escape="true">
1.短期員工福利
短期員工福利係以預期支付之非折現金額衡量，並於相關服務提供時認
列為費用。
2.退休金
(1)確定提撥計畫
對於確定提撥計畫，係依權責發生基礎將應提撥之退休基金數額認列
為當期之退休金成本。
(2)確定福利計畫
A.確定福利計畫下之淨義務係以員工當期或過去服務所賺得之未來福利
金額折現計算，並以資產負債表日之確定福利義務現值減除計畫資產之公
允價值列示。確定福利淨義務每年由精算師採用預計單位福利法計算，折
現率係使用資產負債表日與確定福利計畫之貨幣及期間一致之政府公債
(於資產負債表日)之市場殖利率。
B.確定福利計畫產生之再衡量數於發生當期認列於其他綜合損益，並表達
於保留盈餘。
C.前期服務成本之相關費用立即認列為損益。
3.員工酬勞及董事酬勞
員工酬勞及董事酬勞係於具法定或推定義務且金額可合理估計時，認列
為費用及負債。嗣後決議實際配發金額與估列金額有差異時，則按會計
估計變動處理。
4.離職福利
離職福利係於正常退休日前終止對員工之聘僱或當員工決定接受公司之
福利邀約以換取聘僱之終止而提供之福利。合併公司係於不再能撤銷離
職福利之要約或於認列相關重組成本之孰早時認列費用。不預期在資產
負債表日後12個月全部清償之福利應予以折現。









</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 所得稅</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IncomeTax" contextRef="From20230101To20231231" escape="true">
1.所得稅費用包含當期及遞延所得稅。除與列入其他綜合損益或直接列入權益之
項目有關之所得稅分別列入其他綜合損益或直接列入權益外，餘認列於損益。
2.當期所得稅根據合併公司營運及產生應課稅所得之所在國家，採用在資產負債
表日已立法或已實質性立法之稅率計算。管理階層就適用所得稅相關法規定期
評估所得稅申報之狀況，並在適用情況下根據預期須向稅捐機關支付之稅款估
列所得稅負債。依我國所得稅法規定計算之未分配盈餘加徵所得稅，俟盈餘產
生年度之次年度於股東會通過盈餘分派案後，始就實際盈餘之分派情形認列所
得稅費用。
3.遞延所得稅採用資產負債表法，按資產及負債之課稅基礎與其於資產負債表之
帳面金額所產生之暫時性差異認列。源自於原始認列之商譽所產生之遞延所得
稅負債則不予認列，若遞延所得稅源自於交易(不包括企業合併)中對資產或負
債之原始認列，且在交易當時未影響會計利潤或課稅所得(課稅損失)，且交易
當時並未產生相等之應課稅及可減除暫時性差異，則不予認列。若投資子公司
產生之暫時性差異，合併公司可以控制暫時性差異迴轉之時點，且暫時性差異
很有可能於可預見之未來不會迴轉者則不予認列。遞延所得稅採用在資產負債
表日已立法或已實質性立法，並於有關之遞延所得稅資產實現或遞延所得稅負
債清償時預期適用之稅率為準。
4.遞延所得稅資產於暫時性差異、未使用之課稅損失及未使用所得稅抵減很有可
能有未來課稅所得可供使用之範圍內認列，並於每一資產負債表日重新評估未
認列及已認列之遞延所得稅資產。
5.當有法定執行權將所認列之當期所得稅資產及負債金額互抵且有意圖以淨額
基礎清償或同時實現資產及清償負債時，始將當期所得稅資產及當期所得稅負債
互抵；當有法定執行權將當期所得稅資產及當期所得稅負債互抵，且遞延所
得稅資產及負債由同一稅捐機關課徵所得稅之同一納稅主體、或不同納稅主體
產生但各主體意圖以淨額基礎清償或同時實現資產及清償負債時，始將遞延所
得稅資產及負債互抵。
6.因購置設備或技術、研究發展支出、人才培訓支出及股權投資等所產生之租稅
優惠採用所得稅抵減會計。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td colspan="2">　 其他</td>
					</tr>
					<tr>
						<td style="text-align:center">項目</td>
						<td style="text-align:center">說明</td>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20230101To20231231" escape="true">每股盈餘</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">合併公司列示歸屬於本公司普通股權益持有人之基本及稀釋每股盈餘。基本
每股盈餘係以歸屬於本公司普通股權益持有人之損益，除以當期加權平均流
通在外普通股股數計算。稀釋每股盈餘則係將歸屬於本公司普通股權益持有
人之損益及加權平均流通在外普通股股數，分別調整所有潛在稀釋普通股之
影響後計算。
</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
				</table>
			</div>
			<br />
			<div id="SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計判斷、假設及估計不確性之主要來源</th>
					</tr> 
					<tr>
						<td>　 重大會計判斷、假設及估計不確性之主要來源</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations" contextRef="From20230101To20231231" escape="true">
合併公司於採用附註四所述之會計政策時，對於不易自其他來源取得相關資訊者，
管理階層必須基於歷史經驗及其他攸關之因素作出相關之判斷、估計及假設。實
際結果可能與估計有所不同。
合併公司將氣候變遷及相關政府政策及法規、俄羅斯與烏克蘭軍事衝突及相關國
際制裁、通貨膨脹及市場利率波動所造成之經濟影響納入重大會計估計之考量，
並將持續檢視基本假設及估計。若估計之修正僅影響當期，則於修正當期認列。
若會計估計之修正同時影響當期及未來期間，則於估計修正當期及未來期間認
列。
合併公司編製合併財務報告時，所作會計政策採用之重大判斷、重要會計估計及
假設如下：
(一)會計政策採用之重要判斷 
金融資產分類之經營模式判斷
合併公司依據反映金融資產群組為達成特定經營目的而共同管理之層級，評
估金融資產所屬經營模式。此評估需考量所有攸關證據，包括資產績效衡量
方式、影響績效之風險及相關經理人之薪酬決定方式，且需運用判斷。合併
公司持續評估其經營模式判斷是否適當，並為此監控於到期日前除列之按攤
銷後成本衡量之金融資產及透過其他綜合損益按公允價值衡量之債務工具投
資，瞭解其處分原因以評估該處分是否與經營模式之目標一致。若發現經營
模式已有變更，合併公司依IFRS 9之規定重分類金融資產，並自重分類日起
推延適用。
(二)重要會計估計及假設
1.收入認列
銷貨收入係於移轉商品或勞務之控制予客戶而滿足履約義務時認列，並扣
除估計之相關銷貨退回、折扣及其他類似之折讓。該等銷貨退回及折讓係
依歷史經驗及其他已知原因估計，且合併公司定期檢視估計之合理性。
2.金融資產之估計減損
應收帳款之估計減損係基於合併公司對於違約率及預期損失率之假設。合
併公司考量歷史經驗、現時市場情況及前瞻性資訊，以作成假設並選擇減
損評估之輸入值。所採用重要假設及輸入值請參閱附註六(四)。若未來實
際現金流量少於預期，可能會產生重大減損損失。
3.存貨之評價
由於存貨須以成本與淨變現價值孰低者計價，故合併公司必須運用判斷及
估計決定資產負債表日存貨之淨變現價值。合併公司評估資產負債表日之
存貨因正常損耗、有效期限或無市場銷售價值之金額，並將存貨成本沖減
至淨變現價值。此存貨評價主要係參考目前市場狀況與歷史銷售經驗評估
或依未來特定期間內之產品需求為估計基礎，故可能產生重大變動影響該
等估計結果。
4.不動產、廠房及設備之耐用年限
不動產、廠房及設備以直線法平均攤銷，合併公司定期評估不動產、廠房
及設備之耐用年限及殘值，如相關估計有重大改變時，則於改變當期及以
後年度調整。
5.有形資產及無形資產(商譽除外)減損評估
資產減損評估過程中，合併公司需依賴主觀判斷並依據資產使用模式及產
業特性，決定特定資產群組之獨立現金流量、資產耐用年數及未來可能產
生之收益與費損，任何由於經濟狀況之變遷或公司策略所產生之估計改變，
均可能在未來造成重大減損。
6.遞延所得稅資產之可實現性 
遞延所得稅資產之可實現性主要視未來能否有足夠之獲利或應課稅暫時性
差異而定。若未來實際產生之獲利少於預期，可能會產生重大遞延所得稅
資產之迴轉，該等迴轉係於發生年度認列為損益。


</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>

			<br />
			<div id="TradeAndOtherReceivables"></div>
			<div class="title">應收款項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">明細表</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">項目及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收票據及帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">652,181</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">692,235</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,716</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,046</ix:nonFraction>)</pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">643,465</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">685,189</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ScheduleOfTradeAndOtherReceivables" contextRef="AsOf20231231" escape="true">1.合併公司對商品銷售產生之應收帳款，授信期間為30-210天，係依據交易對手
之產業特性、營業規模及獲利狀況所訂定之授信標準。
2.合併公司未有將應收帳款提供質押之情形。
3.合併公司採用簡化作法按存續期間預期信用損失認列應收票據及應收帳款之備
抵損失。存續期間預期信用損失係考量客戶過去違約紀錄與現時財務及產經狀況
等。依合併公司之信用損失歷史經驗顯示，不同客戶群之損失型態並無顯著差異
，因此準備矩陣未進一步區分客戶群，僅以應收帳款逾期天數訂定預期信用損失
率。
</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">應收款項之帳齡分析</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">帳齡區間及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳齡區間</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">未逾期</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">612,722</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">671,052</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">逾期60天內</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,729</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,920</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">逾期61~120天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">892</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,741</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">逾期121~180天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">122</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">476</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">逾期181天以上</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">643,465</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">685,189</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='3' style="text-align:left">應收款項之備抵損失變動資訊</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本期</th> 
						<th colspan='1'>去年同期</th> 
					</tr>
					<tr> 
						<th style="text-align:center"></th> 
						<th style="text-align:center">金額</th>
						<th style="text-align:center">金額</th>
					</tr> 
					<tr>
						<th style="text-align:left">　期初餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,046</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,536</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　追溯適用IFRS 9影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　提列減損損失</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,681</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">467</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　減損損失迴轉</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　因無法收回而沖銷之款項</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　折現轉回數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　匯率影響數</th>
					　<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　其他</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　期末餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,716</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,046</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='2' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="TransactionsBetweenRelatedParties"></div>
			<div class="title">關係人交易</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<td>　 母公司及最終控制者之名稱</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfParentEntityOrUltimateParentOfGroup" contextRef="From20230101To20231231" escape="true">


本公司為本合併公司之最終控制者。





</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='2' rowspan='1' style="text-align:left">關係人名稱及關係</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">關係人名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係人關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">CANADA BIOTECH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">其他關係人</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">杏達投資股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">其他關係人</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">游淑斐</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">其他關係人</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">全體董事、總經理及副總經理</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">主要管理階層</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
				</table>
			<br />
			<div class="title">與關係人間之重大交易事項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<div style="text-align:center">營業收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">進貨</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應收關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應付關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">預付款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">對關係人放款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td style="width:120px"> 背書保證</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:GuaranteesAmongRelatedParties" contextRef="From20230101To20231231" escape="true">
取得背書保證
合併公司與醫療院所簽訂藥品銷售合約，合約期間為109年7月1日至111年6
月30日。依合約條款由其他關係人杏達投資做為合併公司履行合約之保證
人。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<td style="width:120px"> 其它</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OtherTransactionWithRelatedParties" contextRef="From20230101To20231231" escape="true">
本公司及其子公司（係本公司之關係人）間之交易、帳戶餘額、收益及費損
於合併時全數予以銷除，故未揭露於本附註。合併公司與其他關係人間之交
易如下： 
1.商標及權利金
合併公司與其他關係人CANADA BIOTECH約定，就CANADA BIOTECH授權使用
之商標權，應按年度商品銷售毛利0.02%-0.08%作為權利金並按季給付，全年
度金額不得低於加幣36仟元，112年及111年度合併公司支付之權利金分別
為901仟元及890仟元，帳列「營業費用-推銷費用」項下。
2.其  他
合併公司為整體廠區規劃陸續取得毗鄰本公司之農業用地。依法令規定由
於該等土地尚不得以本公司名義辦理登記為所有權人，故指定合併公司其
他關係人游淑斐小姐為土地之名義持有人，請參閱附註六(八)「不動產、
廠房及設備」之說明。





</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<div style="text-align:center">向關係人借款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr> 
						<th colspan='3' style="text-align:left">主要管理階層薪酬</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本年度</th>
						<th colspan='1'>上年度</th>
					</tr>
					<tr>
						<th style="text-align:left">短期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,635</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,545</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">退職後福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">其他長期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">離職福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">股份基礎給付</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">合計</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,635</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,545</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='3' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="LoansToOthers"></div>
			<div style="text-align:center">資金貸與他人</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="EndorsementGuaranteeProvidedToOthers"></div>
			<div class="title">為他人背書保證</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='15' rowspan='1' style="text-align:left">為他人背書保證</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證者公司名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">被背書保證對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">對單一企業背書保證限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">以財產擔保之背書保證金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">累計背書保證金額佔最近期財務報表淨值之比率</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證最高限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬母公司對子公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬子公司對母公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬對大陸地區背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,239,335</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.97</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,549,169</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,239,335</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">350,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">250,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.07</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,549,169</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,867</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">26.41</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,333</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">280,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-EndorsementGuaranteeProvidedToOthers" contextRef="From20230101To20231231" escape="true">註1：(1)發行人填0。(2)被投資公司按公司別由阿拉伯數字1開始依序編號。
註2：(1)公司直接持有表決權之股份超過百分之五十之公司。(2)直接及間接對公司持有表決權之股份超過百分之五十之公司。
註3：最高限額為背書保證公司財務報表淨值40%。
註4：最高限額為背書保證公司財務報表淨值50%。
註5：係對醫療機構供貨之履約保證。
</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="SignificantIntercompanyTransactionsBetweenConsolidatedEntities"></div>
			<div class="title">母子公司間業務關係及重要交易往來情形</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='8' rowspan='1' style="text-align:left">母子公司間業務關係及重要交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易人名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易往來對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">與交易人之關係</th>
						<th colspan='4' rowspan='1' style="text-align:center">交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">科目</th>
						<th colspan='1' rowspan='1' style="text-align:center">金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">交易條件</th>
						<th colspan='1' rowspan='1' style="text-align:center">佔合併總營收或總資產之比率</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,547</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,972</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">55,097</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,063</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,744</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">租金收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,689</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註5</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,624</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">遞延收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">890</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝藥品工業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">CANCAP PHARMACEUTICAL LTD.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1及2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">勞務費</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,548</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">和田天力沙生藥物開發有限責任公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">進貨</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,763</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">和田天力沙生藥物開發有限責任公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應付帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,714</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註6</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='11' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-SignificantIntercompanyTransactionsBetweenConsolidatedEntities" contextRef="From20230101To20231231" escape="true">註1：母公司及子公司相互間之業務往來資訊應分別於編號欄註明，編號之填寫方法如下：
(1)母公司填0。
(2)子公司依公司別由阿拉伯數字1開始依序編號。
註2：與交易人之關係有以下三種：
(1)母公司對子公司。
(2)子公司對母公司。
(3)子公司對子公司。
註3：交易往來金額佔合併總營收或總資產比率之計算，若屬資產負債項目者，以期末餘額佔合併總資產之方式計算；若屬損益項目者，以期末累積金額佔合併總營收之方式計算。
註4:進銷交易之收(付)款期限及價格依實質交易條件比較與一般客戶並無重大差異，收(付)款條件為30-365天。
註5:租金收取係參考鄰近區域一般租金行情由雙方議定，依合約約定每月定期收取租金。
註6:參考一般市場行情由雙方議定成交價格，授信期間採預訂量預先付款，超過預定量部分依每次議約付款條件付款。
</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence"></div>
			<div class="title">被投資公司名稱、所在地區…等相關資訊</div>
			<div class="rptidx">單位：新臺幣仟元；股數：股</div>
				<table style="width:90%">
					<tr>
						<th colspan='13' rowspan='1' style="text-align:left">被投資公司名稱、所在地區…等相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">地區別代號</th>
						<th colspan='1' rowspan='2' style="text-align:center">所在地區</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">原始投資金額</th>
						<th colspan='3' rowspan='1' style="text-align:center">期末持股情形</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列之投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年年底</th>
						<th colspan='1' rowspan='1' style="text-align:center">股數</th>
						<th colspan='1' rowspan='1' style="text-align:center">比率</th>
						<th colspan='1' rowspan='1' style="text-align:center">帳面金額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">CANCAP PHARMACEUTICAL LTD.(普通股)</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">29</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">加拿大</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">健康食品之製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,605</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,605</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">2,140,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">88.43</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,139</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,139</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">CANCAP PHARMACEUTICAL LTD.(特別股)</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">29</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">加拿大</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">健康食品之製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">126,247</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">126,247</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">51,500</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,394</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,139</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">SUNETIC　BIOTECH INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">132</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">模里西斯</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">投資事業</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">745,748</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">745,748</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">18,854,534</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">83.47</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">815,584</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,648</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">13,146</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">UNIVERSAL NEXT TECHNOLOGIES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">226</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">英屬維京群島</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">投資事業</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,467</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,467</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">503,845</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">杏力醫療器材生技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">醫療器材製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">109,990</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">109,990</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,300,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,199</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,139</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">461</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">生物技術服務業</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,864,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,745,698</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">22,597,472</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">64.26</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">229,301</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">38,172</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,709</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">杏國新藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">SynCore Biotechnology Europe GmbH</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">78</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">德國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">新藥研發及生物技術服務業</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">834</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">834</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">25,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">737</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">子公司</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence" contextRef="From20230101To20231231" escape="true">註1：該投資損益係依台灣母公司簽證會計師查核簽證之財務報表計算而得；並已考量公司間交易之已(未)實現損益之影響數。
註2：杏國新藥股份有限公司於112年5月辦理減資彌補虧損，減資前本公司持股71,456,000股，減資後持股為19,090,513股。
註3：杏國新藥股份有限公司於112年10月辦理現金增資，增資前本公司持股19,090,513股，增資後持股為22,597,472股。
</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="InvestmentInMainlandChina"></div>
			<div class="title">大陸地區投資</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='14' rowspan='1' style="text-align:left">轉投資大陸地區之事業相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">大陸被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">實收資本額</th>
						<th colspan='1' rowspan='2' style="text-align:center">投資方式</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期初自台灣匯出累積投資金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">本期匯出或收回投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期末自台灣匯出累積投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本公司直接或間接投資之持股比例</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末投資帳面價值</th>
						<th colspan='1' rowspan='2' style="text-align:center">截至本期止已匯回台灣之投資收益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">匯出</th>
						<th colspan='1' rowspan='1' style="text-align:center">收回</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20230101To20231231" escape="true">杏輝天力(杭州)藥業有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">原料藥劑等之產銷業務</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">835,133</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">645,635</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">645,635</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,987</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">83.47</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,350</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">840,728</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">179,317</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20230101To20231231" escape="true">和田天力沙生藥物開發有限責任公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">沙生藥物等生產及銷售業務</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,270</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,326</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">75.96</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,673</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,388</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20230101To20231231" escape="true">杭州維存保健食品有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">健康食品之銷售</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">129,810</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">306</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">83.47</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">255</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,526</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='17' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-InformationOfInvestmentInMainlandChina" contextRef="From20230101To20231231" escape="true">註1：該投資損益係依台灣母公司簽證會計師查核之財務報表計算而得。
註2：本期期末累計自台灣匯出赴大陸地區投資金額係包含投審會核准撤銷已出售經由
第三地區投資事業英屬維京群島UNIVERSAL NEXT TECHNOLOGIES INC.以美金200仟元
間接對大陸投資青海明杏生物工程有限公司之股權。
註3：依經濟部投審會規定，其對大陸投資累計金額上限為淨值百分之六十。
</ix:nonNumeric></pre></td> 
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='4' rowspan='1' style="text-align:left">轉投資大陸地區限額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末累計自台灣匯出赴大陸地區投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">經濟部投審會核准投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">依經濟部投審會規定赴大陸地區投資限額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LimitOnInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">杏輝藥品工業股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInvestmentInMainlandChinaAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">652,200</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentAmountAuthorizedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">777,487</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:UpperLimitOnInvestmentInMainlandChinaImposedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,859,002</ix:nonFraction> </pre></td> 
						</ix:tuple>
					</tr>
				</table>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div class="title">營業外收入及支出</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 利息收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2023年1月1日至12月31日</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7101</td>
						<td>　　 銀行存款利息</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,307</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,776</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7105</td>
						<td>　　 其他利息收入</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherInterestIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherInterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7100</td>
						<td>　　 利息收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,307</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,776</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 其他收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2023年1月1日至12月31日</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7110</td>
						<td>　　 租金收入</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:RentIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,880</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:RentIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,731</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7190</td>
						<td>　　 其他收入－其他</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">32,856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,976</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7010</td>
						<td>　　 其他收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,707</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 其他利益及損失</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th> 
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr>					<tr>
						<td>N7210</td>
						<td>　　 處分不動產、廠房及設備利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,126</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">811</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7230</td>
						<td>　　 外幣兌換利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,787</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,311</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7245</td>
						<td>　　 原始認列生物資產及農產品之利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnInitialRecognitionOfBiologicalAssetsAndAgriculturalProduce_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,682</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnInitialRecognitionOfBiologicalAssetsAndAgriculturalProduce_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,293</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7600</td>
						<td>　　 其他利益及損失</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,275</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">752</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7020</td>
						<td>　　 其他利益及損失淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,041</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 財務成本</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr> 
					<tr>
						<td>N7510</td>
						<td>　　 利息費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,711</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,803</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7790</td>
						<td>　　 其他財務費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherFinanceCosts_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherFinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7050</td>
						<td>　　 財務成本淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,711</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,813</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br /> 
			</span>
		</div> 
		<br /> 
	</div> 
</body> 
</html> 

<!--This instance document is created by SIIAP V2.4.9-->

